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ABSTRACT OF THE DISSERTATION
The Role of Synovium Microstructure in Intra-Articular Drug Clearance: A Computational and
Experimental Approach
by
Young Guang
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2020
Professor Lori Setton, Chair

The synovium is a membranous tissue that governs molecular transport between the intraarticular (IA) joint space and the systemic circulatory system. Drug delivery to the IA space is an
attractive option to treat localized joint diseases such as osteoarthritis. However, short residence
times due to rapid clearance from the joint diminishes efficacy of IA injected drugs. While many
studies exist on the clearance of drugs from the IA space, these studies lack the ability to isolate
and characterize trans-synovial transport.
The first aim of this dissertation establishes a computational finite element (FE) model of
trans-synovial transport using multiphasic mixture theory. The model simulates a bolus injection
of drug into a bath representing the joint space, with unsteady drug concentrations over time as
the drug clears from the bath through the tissue. Using parametric studies of the different tissue
material properties, we identified key determinants of transport in the model. Effective
diffusivity (Deff) of the model solute was determined to be the predominant property in
governing transport, and is a property intrinsic to the solute and tissue. Hydraulic permeability
xii

and modulus of the tissue were also identified as relevant to solute transport under conditions
with sufficient fluid movement through the tissue. Given the lack of knowledge of material
properties of the synovium, the parametric studies were used to inform selection of material
properties to be used in the model.
In the second aim of this dissertation, an experimental model using devitalized porcine
and human synovial explant tissue was combined with the model developed in the first aim to
study the effect of molecular weight on Deff. Different molecular weight molecules, ranging
from 60 Da – 70 kDa, were sampled from the upstream bath in an unsteady model of transport.
The bath concentration profile was described with the using the computational model and with a
single exponent curve-fit. This yielded parameters of Deff from the computational model and a
time-constant from the exponential curve-fit. The two parameters correlated well with one
another when sample thickness was controlled for, indicating the importance of geometry when
evaluating intra-articular transport. This aim represents the first reports of solute diffusivity as
dependent on molecular weight through the synovium, a key measurement towards
understanding trans-synovial transport.
In the final aim of this dissertation, the synovium underwent mechanical testing to
determine previously unmeasured properties of the tissue relevant to transport. Synovial tissue
underwent a confined compression stress-relaxation experiment to measure the modulus and
hydraulic permeability of synovial tissue. Synovium modulus was found to be much softer than
moduli of other joint tissues. Values of hydraulic permeability were estimated to be much lower
than in any other connective tissue. The evaluation of modulus and permeability allows for
refinement of the model used to estimate solute diffusivity in the previous aims.

xiii

The work presented in this dissertation improves our understanding of the role molecular
weight and synovium tissue properties have in governing trans-synovial transport. This work
forms the basis for more complex models of transport incorporating charge, active transport, and
intra-articular pressure, towards the goal of predicting factors that regulate solute clearance in
healthy and pathological synovium.

xiv

Chapter 1: Introduction
1.1 Osteoarthritis and Diseases of the Joint
Arthritis is a common chronic condition that afflicts one or multiple joints. In the United
States, arthritis is the leading cause of disability affecting 54 million adults or 23% of the
population (Lawrence et al. 2008; Centers for Disease Control and Prevention (CDC) 2009;
Barbour et al. 2017). Aging is the primary risk factor associated with all types of arthritis, and
the prevalence of arthritis is expected to increase with the aging population; other risk factors
include obesity, genetics, diet, and trauma. The most common type of arthritis is osteoarthritis
(OA), a degenerative disease of the joint, which affects over 30 million adults in the United
States (Cisternas et al. 2016). Pain associated with OA limits mobility and activity, and has also
been associated with a higher risk of all-cause mortality (Palazzo et al. 2016). The economic
impact of OA alone due to direct and indirect healthcare costs in the United States has been
estimated to be $140 billion in 2013 (Murphy et al. 2018). There is a significant burden of OA,
both in patient quality of life and economic burden, but there is no known cure for the disease.
Historically, OA was characterized primarily by the degradation of articular cartilage, the
connective tissue lining the articulating surfaces of bone that contributes to lubrication and
gliding motions of the joint. Other hallmarks of OA include osteophyte formation, subchondral
bone formation, and synovial inflammation, with OA now being recognized as a disease of the
whole joint. Further, while OA has historically not been seen as an inflammatory disease, unlike
rheumatoid arthritis (RA), symptoms such as joint pain, swelling, and stiffness, as well as
1

evidence of inflammatory cytokine production by synovial cells and chondrocytes implicate
involvement of inflammation in disease progression (Goldring and Otero 2011). The increased
recognition of inflammation in OA has led to an increased interest in the synovium, which is one
of the main sites of inflammation in the joint.
Treatment options for arthritis are severely limited, with most treatments aiming to
address the pain associated with arthritis. At the early stages of OA, the pain management relies
on non-steroidal anti-inflammatory drugs (NSAIDs) and other analgesics, as well as lifestyle
changes to address obesity and promote increased physical activity (Kapoor et al. 2011b). As
pain progresses, non-surgical drug options include local injections of corticosteroids and
viscosupplements to delay surgical intervention, although these treatments only provide
temporary relief and do not inhibit disease progression (Oo et al. 2018). Ultimately, when the
pain becomes unbearable, a total joint replacement is necessary, which may be tolerated for older
patients; younger patients often will require a revision surgery in their lifetime (Losina and Katz
2012). Drug therapies have been developed to inhibit disease progression and delay a total joint
replacement (Chevalier et al. 2009). Recently, tanezumab, a nerve growth factor inhibitor, has
passed phase III clinical trials to manage pain in OA when delivered subcutaneously (Berenbaum
et al. 2020). These therapies are typically delivered systemically, which has led to increased
interest in an intra-articular formulation to treat individual joints (Fisher and Keat 2006).

1.2 Intra-Articular Drug Delivery
Intra-articular (IA) drug delivery, or the local injection of a therapeutic agent to the intraarticular space, is an attractive option for treating joint diseases, with many benefits over
systemic delivery. These benefits include increased bioavailability at the affected site, reduced
2

systemic exposure, fewer side effects, and lower total drug cost (Evans, Kraus, and Setton 2014).
Benefits of IA drug delivery may be limited, however, by rapid clearance of the injected drug
from the joint space (Wallis et al. 1985; Gerwin, Hops, and Lucke 2006). For example, the
residence times of unmodified steroids after IA injection may be less than 2 hours and some
hyaluronan visco-supplements may have half-lives of hours depending on formulation (Table
1.1) (C. Larsen et al. 2008); an ideal bolus drug delivery would last in the joint for weeks to
months to mitigate symptoms over a prolonged period of time. While studies of drug clearance
kinetics have been performed in pre-clinical models and human subjects, there remains a dearth
of knowledge regarding the factors regulating IA residence time. RA is commonly treated with
systemically delivered drugs, although flare-ups and pain present in specific joints can be
targeted with an IA delivery. OA is found in individual joints, and therefore a prime candidate
for IA injections to the afflicted joint, especially in cases when the joint fails to respond to drugs
approved for systemic delivery to treat OA.
The earliest recorded clinical IA drug delivery was in the 1930’s consisting of formalin
and glycerin, lipodol, lactic acids, and petroleum jelly (Lavelle, Lavelle, and Lavelle 2007); there
were few if any positive effects noted. In the 1950’s Hollander reported on the first IA injections
of corticosteroids in patients with RA (Hollander et al. 1951), and indeed, later studies showed
clinical efficacy of IA delivery vs. systemic delivery of steroids in RA patients (Furtado,
Oliveira, and Natour 2005). Corticosteroids are small hydrophilic molecules (~300 Da) that
reduce pain in both RA and OA by modulating the inflammatory response through reducing
release of inflammatory mediators (Uthman, Raynauld, and Haraoui 2003). Due in part to their
small molecular weight, many corticosteroids have a reported half-life of less than 2 hours
(Table 1.1) following IA injection as estimated using radioimmunoassays from human plasma
3

(Derendorf et al. 1986; Winter et al. 1967; Peterson, Black, and Bunim 1959). Despite the
limited residence time, patient outcomes with respect to pain have shown improvement up to 3
weeks following injection compared to a placebo (Creamer 1999).
Another common therapeutic in IA delivery are hyaluronans, which are thought to be one
of the main contributors to synovial fluid lubrication within the joint. IA injection of hyaluronans
are meant to act as a viscosupplement to endogenous lubricants to reduce the mechanical loads in
the joint (Marshall 2000). Given their polysaccharide structure, hyaluronan has a wide range of
molecular weights, with average molecular weights in native synovial fluid ranging from 3-7
MDa (Fraser, Laurent, and Laurent 1997; Saari et al. 1993). Exogenous formulations of
hyaluronan (HA) of similar molecular weights have reported half-lives ranging from 12 hours to
24 hours based on radiolabeled HA studies in animal models (T. Brown, Laurent, and Fraser
1991; Coleman et al. 1997). Viscosupplements are one of the most commonly IA injected
therapeutics, however, meta-analyses show limited efficacy (Rutjes et al. 2012).
Systemically delivered biologic agents that have been successful for treatment of RA
have seen increased interest in IA for localized treatment. Many of these agents are undergoing
clinical trials, but face challenges related to joint pharmacokinetics(Evans, Kraus, and Setton
2014). These soluble proteins, despite their large molecular weights typically have half-lives of
4-6 hours (Table 1.1, anakinra) which may be due to factors such as their globular structure and

4

Table 1.1 Synovial disappearance half-lives calculated as half-life of decay of synovial fluid
concentration following intra-articular injection of therapeutics with molecular weights.
*calculated as half-life of decay of plasma concentration following systemic delivery.

Cortisone

Diclofenac

Paracetamol

2.5-4.2

1.4

5.2

1.1

362 Human RA

362 Human RA

360 Human RA

296 Human RA

151 Human RA

MW (Da) Injection Site
138 Human RA

Hydrocortisone
1.42

Drug Name t1/2 (h)
Salicylic acid
2.4

Hydrocortisone

375 Horse Knees
454 Human RA

1.7
2.9

Prednisolone
Methotrexate

Anakinra
Hyaluronan

9-12 days

4-6
10.2

149,000 Human RA,
systemic
3,000,000 Rabbit Knee

5.1

Infliximab*

21.8-26.3

6,000,000 Rabbit Knee

Ceftiofur

Hyaluronan

13.2

524 Horse
antebrachiocarpal
joint
17,300 Human RA
90,000 Rabbit Knee

Hyaluronan

(FDA Access)
(Brown et al.
1991)
(Klotz et al. 2007)

(Milis et al. 2000)

Notes
References
NSAID (COX2 inhibitor), High- (Owen et al.
performance liquid
1994)
chromatography, synovial fluid
NSAID (Tylenol), High(Owen et al.
performance liquid
1994)
chromatography, synovial fluid
NSAID, High-performance liquid (Owen et al.
chromatography, synovial fluid
1994)
Steroid, chromatography
(Peterson et al.
1959)
Steroid, Radiolabel (C14),
(Winter et al.
radioassay
1959)
Steroid, chromatography
(Peterson et al.
1959)
(Soma et al.
2006)
(Wigginton et al.
1980)
Steroid, High-performance liquid
chromatography, synovial fluid
Immunosurpressor,
Radioimmunoassay, synovial
fluid and plasma
Antibiotic, agar gel diffusion
assay, plasma and synovial fluid

IL-1ra
Radiolabel (H3) Plasma
TNFalpha blocker, serum
estimates, elimination half life
Liquid Chromatography from
Synovial Fluid Aspiration
Radiolabel (H3), Plasma

(Coleman et al.
1997)
(Brown et al.
1991)

5

affinity for charge (C. Larsen et al. 2008).
IA drug delivery has shown efficacy in treatment of local arthrides and pain over
systemic deliveries. With treatments limited in their efficacy due to rapid clearance from the
joint, there is an increased need to improve residence times within the joint. Crucial to
understanding the drug kinetics following IA injection is studying the synovium.

1.3 The Synovium
The synovium is a thin multi-layered membranous tissue that surrounds articulating joints
and plays roles in regulating transport into and out of the joint space, as well as synthesizing key
synovial constituents responsible for lubrication such as lubricin and hyaluronic acid (HA)
(Schmidt and Sah 2007). Structurally, the synovium can be broken down into two separate layers
consisting of a cellular intima overlaying a loosely connected subintima (Figure 1.1) (Barland,
Novikoff, and Hamerman 1962). The joint-space facing layer, the intima, is a co-compacted cell
layer, 2-4 cells thick consisting of ~90% fibroblast-like synoviocytes (FLS) and ~ 10%
macrophage-like synoviocytes (MLS) in healthy synovium (Valencia et al. 2004; Castor 1960).
Though similar to cell linings found in epithelia, the intimal cell lining does not form a
continuously compacted layer, instead forming in discrete clusters, with large intercellular spaces
between them (Knight and Levick 1984). These cells are surrounded by a dense fibrillar matrix
containing little type I collagen, instead being comprised of collagens III-VI; additionally, the
intima lacks a basement membrane as found in other lining surfaces in the body, although the
intimal extracellular matrix (ECM) consists of many basement membrane proteins such as
fibronectin, laminin, sulfated proteoglycans, as well as collagen IV (Revell et al. 1995). This
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structure makes the synovial intima unique as the cellular layer is composed of densely packed
cells in a dense extracellular matrix.

Figure 1.1 Schema of synovial tissue intima and subintima with FLS and MLS subpopulations and vessels in the sub-intima.
Underneath the intimal layer is the sub-intima, which is a layer of relatively acellular
collagenous connective tissue that is up to 5mm thick (Smith 2011). Dispersed throughout the
sub-intima are blood vessels, fat cells, lymphatic vessels, and both FLS and MLS. Directly below
the intimal surface lies a capillary bed of both fenestrated and unfenestrated vessels (Wilkinson
7

and Edwards 1989). Further in from this capillary bed are the lymph vessels as well as larger
arterioles and venules (H. Xu et al. 2003). The composition of the sub-intimal ECM varies
depending on location within the joint and the underlying tissue, with synovium overlaying fat
pads consisting of more adipose cells (Figure 1.2a) and synovium overlaying fibrous tissues such
as tendons and ligaments being made up of primarily type I collagen (Figure 1.2b). The most
common sub-type is areolar synovium (Figure 1.2c) which overlies loose connective tissue, with
the ECM dominated by type I collagen and glycosaminoglycans (GAGs) (Smith 2011). The
GAGs found in normal areolar synovium are similar to those found in other musculoskeletal
tissues such as cartilage and the intervertebral disc, including hyaluronan, chondroitin sulphates
and heparin sulphates (Farndale, Buttle, and Barrett 1986; Liu et al. 2018; Price, Levick, and
Mason 1996). Studies suggest these hydrophilic GAGs are important for the synovium’s ability
to maintain synovial fluid homeostasis in the intra-articular space (Scott et al. 1997). Changes to

a

b

c

Figure 1.2 histological sections of healthy synovium subtypes stained with hematoxylin and
eosin (x200 magnification) a) adipose b) fibrillar and c) areolar
the synovial ECM components in pathology however, are not as well studied, due in part to the
difficult of sourcing and handling tissue.
Synovial inflammation, or synovitis, is recognized as a feature of many joint pathologies
such as RA and OA. While synovitis has been commonly associated with RA, there is increasing
interest in studying synovial inflammation in OA as a potential mediator of disease progression
8

and potentially a therapeutic target (Pelletier, Martel-Pelletier, and Abramson 2001). In OA, the
synovium thickens in both the intimal and subintimal layers forming a pannus with increased
cellularity, vascularization, and fibrosis (Shibakawa et al. 2003; Mathiessen and Conaghan
2017). Hyperplasia is one of the key features of synovitis, with the intimal lining increasing to up
to 6 cells thick, the subintima being infiltrated with cells, and an increased proportion of MLS in
both (Wilkinson et al. 1990; Yuan et al. 2003). As with inflammation in other tissues,
angiogenesis is prevalent in OA synovitis, with blood vessel density and size increasing
throughout the synovium (Henrotin, Pesesse, and Lambert 2014). While in RA synovitis, the
number of lymphatic vessels increases, studies in OA synovitis show decreases in number of
lymphatic vessels in OA, however in both RA and OA there is failure of lymphatic drainage (Shi
et al. 2014). Synovitis in OA has been linked with cartilage degradation through increased proinflammatory cytokine production from FLS, primarily interleukin-1 beta and tumor necrosis
factor-alpha (Kapoor et al. 2011a; Scanzello and Goldring 2012). These aberrant changes to the
synovium can precede cartilage degradation in OA (Hügle and Geurts 2017). The pathologic
changes to the synovium in OA are known to alter the clearance of molecules from the synovial
fluid through the synovium, however, the mechanism by which this works remains unknown
(Bhattaram and Chandrasekharan 2017). Further, mass transport within the healthy native
synovium remains an understudied area despite the importance of the synovium in regulating
transport.

1.3.1 Morphometry and imaging studies of the synovium
Clinically, physicians use magnetic resonance imaging or ultrasound to assess the
synovial structure, however these imaging modalities lack sufficient resolution to evaluate the
morphometric properties of synovial tissue. As with many other tissues, the earliest evaluations
9

of synovial structure was performed through thin tissue sections of synovial biopsies (Figure
1.3a), though more recent histology has revealed further insights with the improvement of
microscopy (Davies 1950; Cochrane, Davies, and Palfrey 1965; Smith et al. 2003; Singh et al.
2004; Castor 1960). These studies first characterized the synovium into layers that today are
referred to as the intima and sub-intima (Smith 2011). Electron-microscopy of the synovium
(Figure 1.3b) was crucial in identifying the vascular bed in the sub-intima consisting of
fenestrated and non-fenestrated blood vessels within the first 40 µm of the intimal surface
(Barland, Novikoff, and Hamerman 1962; Dryll et al. 1977; Pasquali-Ronchetti et al. 1992;
Knight and Levick 1983). These studies also demonstrated wide intercellular gaps in the intima
ranging from 0.1 – 5.5 µm (Knight and Levick 1984). Lymphatic vessels have been generally
lesser studied, though there is increasing interest in lymphatic imaging (Figure 1.3c) because of
their role in IA clearance (H. Xu et al. 2003; Shi et al. 2014). One of the most recent studies
investigating synovial microstructure used multi-photon microscopy combined with antibody
labelling to visualize the transport of an intravenously delivered RA drug (CTLA-4 IG,
Abatacept) in pathologic collagen-induced arthritis (Figure 1.3d), reporting increased lymphatic
drainage in the acute inflamed stage of arthritis compared to the chronic (Hasegawa et al. 2020).
Understanding the morphometric features, as illustrated by some of the aforementioned studies,
helps our understanding of drug transport following IA injection.
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Figure 1.3 a) histological thin section of synovium from a human hip joint at x35
magnification adapted from (Davies 1950) b) electron micrograph of rabbit knee synovium at
x 8400 magnification capable of resolving cell populations and capillaries close to the
synovium joint space interface from (Knight and Levick 1984) c) Fluorescent images of a
mouse knee a x20 magnification (left) with x800 magnification insets showing staining of
podoplanin (red, left inset), 𝛼SMA (green, middle inset), and overlay (right inset) to identify
mature lymphatic vessels (Shi et al. 2014). d) multiphoton tile scan of mouse synovium with
fibrous tissues and bone visualized with second harmonic generation (blue), labeled drug
(red), and antibody labelled podoplanin (green). Scale bar is 50µm) from (Hasegawa et al.
2020)
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1.3.2 Drug transport in synovium in vivo
Most of our knowledge on IA drug transport is based on observations made half a century
ago. These early reports observe molecules exiting the joint space independent of molecular
weight, in contrast to the size-dependent manner through which they enter the joint space from
the systemic circulatory system, suggesting lymphatic drainage may be primarily responsible for
transport of large molecules (Wallis, Simkin, and Nelp 1987; Levick 1981). This is in contrast to
small molecules, which are thought to be transported in a manner dependent on diffusion through
the synovial lining (C. Larsen et al. 2008; Knight and Levick 1984; Simkin and Pizzorno 1974).
Historically, intra-articular drug clearance studies utilized in vivo radiolabels and
sacrificial end points to estimate drug residence times (Albuquerque and De Lima 1990; Simkin
2013). Some of the earliest studies injected radiolabeled molecules into human RA knees and
measured the radiation using scintillation counters placed around the knee joint (Harris, Millard,
and Banerjee 1958; Ahlström, Gedda, and Hedberg 1956). While these early in vivo studies
provided temporal clearance data around the knee joint, they were unable to provide spatial
information regarding transport. To that end, studies using radiolabels of injected molecules such
as immunoglobulins and albumin, were carried out by multiple groups, in which either blood
plasma or synovial effusions were collected for clearance estimation in addition to scintillation
measurements at the joint (Rodnan and Maclachlan 1960; Sliwinski and Zvaifler 1969). By
sampling blood plasma, the radiolabeled compounds are diluted by the large total blood volume
leading to low levels of detection. Synovial effusions, on the other hand, alter the total amount of
drug present in the joint due to the required volume needed to obtain a measurement, impacting
apparent clearance times (Owen, Francis, and Roberts 1994). Neither of these sampling methods
are capable of providing sufficient levels of detection to estimate drug transport spatially.
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Antonas and co-workers attempted to address this in a study using IA injected radioactive
hyaluronic acid in rabbit knees, however their study required sacrificial end points in order to
obtain measurements of radioactivity in the tissues in and around the joint, including the
synovium, thus lacking the ability to estimate transient drug transport (Antonas, Fraser, and
Muirden 1973). While the use of radiolabels provided high precision in detecting drug
concentrations the types of solutes available to study were limited due to the complexities
associated with handling; additionally there are concerns about safety and radioactive half-lives
of these compounds (Wu and Ju 2012; N. E. Larsen et al. 2012).
Recent advancements in near infrared (NIR) fluorophores and in vivo imaging systems
have led to studies of intra-articular clearance in living animals, capable of estimating drug
concentrations in the joint using a wide range of compounds, spanning different molecular
weights (Figure 1.4a) (Whitmire et al. 2012; Butoescu et al. 2009). Some of the most recent
studies investigate the role of disease and lymphatic function in IA clearance. Work by Mwangi
and co-workers reported on IA transport of fluorescently labelled dextrans of two different
molecular weights (500 kDa vs 10 kDa) in healthy and OA rat knee joints, with results that
indicated slower transport for larger compared to smaller molecular weight dextrans. One
important finding of Mwangi and co-workers was the spatial distribution of solutes measured
through synovial thickness using non-optical microscopy. They further reported that transport of
the larger molecular weight dextran was impaired in the OA model due in part to the increased
synovial thickness (Figure 1.4b), however one of the major limitations of the study was the need
to sacrifice animals at discrete timepoints to obtain temporal data (Mwangi et al. 2018). Another
study by Doan and colleagues reported similar size-based results using NIR technology, while
also investigating the role of lymphatic drainage implicating the process of lymphatic drainage in
13

large molecular weight clearance (Figure 1.4c) (Doan et al. 2019). While such in vivo studies
have provided valuable data on residence times and distribution through the body, the techniques
used lack proper spatial resolution to understand the properties that govern trans-synovial
transport without sacrificial endpoints utilizing histological sections (Figure 1.4d and e).
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Figure 1.4 a) in vivo imagingof NIR fluorescent molecules following injection into the rat
knee joint adapted from (Butoescu et al. 2009). b) Transport of different molecular weight
dextrans in healthy and OA rats (Mwangi et al. 2018) c) Biodistribution of NIR tagged
molecules show evidence of lymphatic clearance for the high molecular weight solute only
(Doan et al. 2019) d) (scale bar = 100µm) and (e) (scale bar = 50µm) show the spatial
distribution of fluorescent molecules in histological sections of joint tissue obtained at
sacrifice (adapted from Mwangi et al. 2018 and Whitmire et al. 2012, respectively).
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1.3.3 Drug transport in synovium in vitro
In attempts to address the trans-synovial transport kinetics, various in vitro systems have
been investigated. Cellular based approaches, including cell monolayers of the intimal layer and
microphysiological systems of synovium, have identified the role of the intima as a size-selective
barrier to macromolecules, but provide no insight into the transport properties of the native
extracellular matrix in the sub-intima (Blewis, Lao, Jadin, et al. 2010; Stefani et al. 2018;
Blasioli, Matthews, and Kaplan 2014). Recently Stefani and co-workers assessed the
permeability of 70 kDa dextran in bovine synovium explants using a Transwell® system. While
the authors identified differential transport behaviors between native synovial tissues and an
engineered micro-physiological model, intrinsic solute diffusivities within explant tissues could
not be obtained as transport times in that study depended on geometry of the synovium and other
variables (Stefani et al. 2018). In a similar study, Sterner and co-workers used customized
diffusion chambers to measure passive diffusion of polyethylene glycol polymers (6-200 kDa)
across bovine synovium and found a correlation between polymer molecular weight and
transport speed (Sterner et al. 2016). As for the explant study by Stefani and co-workers, this
work provides insight into trans-synovial transport but presents measurements such as transport
speed or time that depend on experimental conditions that can vary across specimens. These
prior synovial explant studies could benefit from a mechanistic model that allows for
measurement of intrinsic transport properties that are independent of measures such as sample
size, morphology, and composition.

1.3.4 Mathematical models of molecular transport from synovium to joint
Our current models of molecular transport in synovium rely heavily upon the analytic
work of Levick and co-workers, from the 1980s-1990s. In the most sophisticated of these
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models, Levick constructed the equivalent of a compartmentalized Fickian transport model to
represent different layers that he perceived to exist in synovial tissue (Levick 1984). Levick used
morphometric data from rabbit histologic sections to propose solute flux into each compartment
from the systemic circulation (i.e., source), based on the density of fenestrated and continuous
capillaries in each layer. A mass balance law was used for each layer so that solute inflow would
be cleared from the tissue into the joint cavity (i.e., sink),
𝐽𝑖(𝑑+Δ𝑥) =

𝐷𝑖 𝐴𝑖 (𝐶𝑖(𝑑+Δ𝑥) −𝐶𝑖(𝑑) )
Δ𝑥

(1.3.1)

Where 𝐽𝑖(𝑑+Δ) represents the flux in the synovium at a depth of 𝑑 + Δ𝑥, 𝐷𝑖 and 𝐴𝑖 represent the
diffusivity and cross-sectional area of the synovium respectively, and 𝐶𝑖 represents the solute
concentration at the mid-slice. Levick’s goal was to determine diffusional flux due to sub-intimal
diffusivity (𝐷𝑡 ) and that due to capillary endothelium (𝐷𝑖 ). He presented a “fractional
endothelial resistance” that was important for understanding circulatory supply to the joint from
the systemic circulation. This work has long been the only method to determine a diffusivity for
tissue (𝐷𝑡 ) and also for capillary endothelium (𝐷𝑖 ).

1.4 Finite Element Modelling
The finite element (FE) method is a numerical method for solving differential equations
where it is difficult to achieve a closed-form solution due to complex boundary conditions or
geometry. Historically, FE was originally used to solve problems in mechanics, but has since
covered virtually every field in physics and engineering from fluid transport to heat transfer.
FEM divides a structure into discrete elements connected together at nodes to form a mesh made
up of these finite elements. Then by applying the proper boundary conditions and differential
equations in the form of a boundary value problem to the finite elements a system of algebraic
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equations is formed. Through solving the equations at each element and node, a numerical
solution can be obtained for the entire system through interpolation (de Weck and Kim 2004).
The FE algorithm solves the systems of equations through minimizing energy in the system
along with laws of balance to estimate the unknown field variables dictated by the constitutive
model. In practice, the FE formulations is implemented as a weak form of the physical
constitutive equations such as the concept of virtual work or conservation of linear momentum
(Maas et al. 2019).
The systematic approach of breaking a complex system down into individual elements
and their contributions lends itself well to problems in biomechanics. The geometries
encountered in biological systems from the molecular to organ level are intricate and diverse, a
problem that is well addressed by the discretization in FE. Further, the methodology is able to
manage material heterogeneity and differences in constitutive equations across the model. Many
of the first applications of FEM to biomechanics was in cardiac solid and fluid mechanics
(Davids and Mani 1974; Doyle and Dobrin 1971; Janz and Grimm 1972), that expanded to
include other tissues (Farah, Craig, and Sikarskie 1973; Belytschko et al. 1974). These early FE
biomechanics models used constitutive models and commercial packages from other engineering
fields as opposed to formulations specifically for biomechanics (Maas, Ateshian, and Weiss
2017).
One of the major limitations early in biomechanics FE modeling was the lack of
poroelastic implementation in most packages. This led to researchers developing their own
custom code to work with available solvers to model soft tissues as a mixture of fluids and
solids, including biphasic formulations (Simon et al. 1985; Spilker and Suh 1990). However,
these custom written codes were difficult to validate and were also coded specifically for the
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problem at hand, making reproducibility a problem (Maas, Ateshian, and Weiss 2017). To
address this limitation, Maas and co-workers at University of Utah and Columbia University
developed FEBio®, an open-source finite element framework for solid mechanics, fluid
mechanics, biphasic and multiphasic mixture theory, electrokinetics, and more for use at multiple
length scales from cellular, tissue, and organ level (Maas et al. 2012; Ateshian, Maas, and Weiss
2013).

1.5 Multiphasic Mixture Theory
Multiphasic mixture theory may be used to model a deformable porous media consisting
of multiple phases: solid, fluid and solutes. This framework is a natural extension of biphasic
mixture theory developed by Mow and coworkers which describes the behavior of materials
consisting of a fluid and solid phase (Mow et al. 1980). Biphasic and multiphasic theory have
been used to describe the behavior of many biological hydrated tissues such as cartilage, cells, as
well as of hydrogels used in tissue engineering (Mauck, Hung, and Ateshian 2003; Ateshian et
al. 1997; Athanasiou et al. 1991; Spilker and Suh 1990). In these model descriptions, the solid
phase is assumed to be a porous skeleton that is permeable to fluid flow, which is assumed to be
inviscid. The solute phase(s) is treated as additional fluid phases, with the assumption that the
mass of solute is negligible compared to the mass of the fluid and solid phases – in other words,
a solid molecule and a fluid molecule will “see” one another with regards to transfer of energy
and momentum, but neither will “see” a solute molecule. Each phase is considered to be
intrinsically incompressible, in that the volume of the constituent does not change, but an
apparent change in volume of the mixture is due to the exchange of fluid within the pores of the
solid phase as the pores change in size due to solid deformation. While the solute phase and the
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solid phase may independently hold charge, the mixture as a whole must satisfy electroneutrality.
Finally, the “friction”, or momentum transfer, due to interactions modeled between fluid, solid,
and solutes is much larger than friction generated due to interactions within each constituent.
The mathematical formulation of mixture theory is based on continuum mechanics where
the material is treated as a continuous mass such that the space is completely filled with the
mixture. Using kinematic continuum mechanics principles, each constituent 𝛼 has separate mass
and motion which must satisfy separate conservation equations. In treating each constituent
separately with their own mass 𝑚𝛼 and volume 𝑉 𝛼 , the following definitions arise:
𝜌𝑇𝛼 =

𝜌𝛼 =

𝑑𝑚𝛼
𝑑𝑉 𝛼

𝑑𝑚𝛼
𝑑𝑉

true density

(1.5.1)

apparent density .

(1.5.2)

Additionally, the following definitions for volume fraction:
𝜙𝛼 =

𝑑𝑉 𝛼
𝑑𝑉

𝜌𝛼

= 𝜌𝛼

(1.5.3)

𝑇

such that
∑𝑛𝑖=1 𝜙 𝑖 = 1

(1.5.4)

for n constituents in the mixture.
Here, 𝛼 = 𝑠 for the solid phase, 𝛼 = 𝑤 for the solvent phase, and 𝛼 = 𝑢 for the solute
phase. Through summing each constituent’s conservation equations together, the conservation
equations for the mixture as a whole may be obtained. The governing equations in mixture
theory are the conservation of linear momentum and the conservation of mass. By assuming
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quasi-static conditions and in the absence of body forces, the conservation of linear momentum
for the mixture reduces to
div(𝝈𝒔 ) = 0

(1.5.5)

where 𝝈𝒔 is the solid stress. The balance of linear momentum for the solvent and solute phase
are, respectively
−𝜌𝑤 grad 𝜇̃𝑤 + 𝒇𝑤𝑠 ∙ (𝒗𝑠 − 𝒗𝑤 ) + 𝒇𝑤𝑢 ∙ (𝒗𝑢 − 𝒗𝑤 ) = 0

(1.5.6)

−𝜌𝑢 grad 𝜇̃𝑢 + 𝒇𝑢𝑠 ∙ (𝒗𝑠 − 𝒗𝑢 ) + 𝒇𝑤𝑢 ∙ (𝒗𝑤 − 𝒗𝑢 ) = 0

(1.5.7)

Where 𝒇𝛼𝛽 is the diffusive drag tensor for the momentum exchanged between constituents 𝛼 and
𝛽, 𝒗𝛼 is the velocity of constituent 𝛼, and 𝜇̃𝛼 is the mechano-chemical potential as given by,
1

𝜇̃𝑤 = 𝜇̃0𝑤 (𝑇) + 𝜌𝑤 (𝑝 − 𝑅𝑇Φ ∑𝛼 𝑐 𝛼 )

(1.5.8)

𝑇

𝜇̃𝑢 = 𝜇̃0𝑤 (𝑇) +

𝑅𝑇
𝑀

𝛾𝑐

ln (𝜅𝑐 )
0

(1.5.9)

when utilizing the assumption that solute volume fraction is negligible compared to the solid and
solvent volume fractions (𝜙 𝑢 ≪ 1). These mechano-chemical potentials are the sum of the
mechanical and chemical potentials that arise from classical physical chemistry (Allen 2008). In
the expressions for the mechano-chemical potentials, 𝜇̃0𝛼 are the chemical potentials for the
constituents in a reference state at a given absolute temperature 𝑇, 𝑅 is the ideal gas constant, 𝑝
is the fluid pressure, Φ is the osmotic coefficient, and 𝑀 is the molecular weight of solute 𝑢. The
𝛾𝑐

term 𝜅𝑐 represents the activity of the solute wherein 𝛾 is the non-dimensional activity
0

coefficient, 𝑐 is the solute solution-volume concentration, 𝑐0 is the concentration in a reference
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state, and 𝜅 is the solubility, which is representative of the pore space available to the solute.
Under ideal physico-chemical conditions, 𝛾 and Φ reduce to unity.
In order to satisfy the balance of mass for each constituent 𝛼, equations (1.5.6) and
(1.5.7) reduce to,
𝜕𝜌𝛼
𝜕𝑡

+ div(𝜌𝛼 𝒗𝛼 ) = 0

(1.5.10)

As apparent density may be related to true density (a constant) through volume fraction,
𝜌𝛼 = 𝜙 𝛼 𝜌𝑇𝛼

(1.5.11)

and the sum of all volume fractions is unity, the mass balance for the mixture may be written as:
div(𝜙 𝑠 𝒗𝑠 + 𝜙 𝑤 𝒗𝑤 + 𝜙 𝑢 𝒗𝑢 ) = 0

(1.5.12)

With use of the assumption of 𝜙 𝑢 ≪ 1, this may be rewritten as
div(𝒗𝑠 + 𝒘) = 0

(1.5.13)

where 𝒘 is the volumetric fluid flux of solvent relative to the solid as defined by
𝒘 = 𝜙 𝑤 (𝒗𝑤 − 𝒗𝑠 )

(1.5.14)

Similarly, the molar flux of solute relative to the solid matrix is defined as
𝒋 = 𝜙 𝑤 𝑐(𝒗𝑢 − 𝒗𝑠 )

(1.5.15)

Through inverting the momentum equations (1.5.6-7), the fluid and solute fluxes (1.5.14-15) can
be related to the mechano-chemical potentials as
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𝒅

𝒘 = −𝒌 ∙ (𝜌𝑤 grad 𝜇̃𝑤 + 𝑀𝑐 𝑑 grad 𝜇̃𝑢 )
0

𝑀

𝑐

𝒋 = 𝒅 ∙ (𝑅𝑇 𝜙 𝑤 𝑐 grad 𝜇̃𝑢 + 𝑑 𝒘)
0

(1.5.16)

(1.5.17)

Where 𝒌 is the hydraulic permeability tensor in the mixture, 𝒅 is the diffusivity tensor in the
mixture, ands 𝑑0 is the isotropic diffusivity in free solution. In the absence of osmotic pressure
(𝜇̃𝑢 = 0), equation (1.5.16) reduces to Darcy’s law of fluid movement through a porous material.
Similarly, equation (1.5.17) combined with equation (1.5.9) in the absence of fluid movement
(𝒘 = 0), in completely free solution (𝜙 𝑤 = 1), and under ideal physio-chemical conditions
(𝛾, Φ = 1) reduces to Fick’s law of diffusion.
Using this formulation, experimental test conditions of interest can be described,
including application of surface tractions using the biphasic formulation, and solute transport
through the multiphasic formulation. These general formulations can be expanded upon further
to include interactions of charge and solute consumption. Here this formulation will be used to
develop a tissue level model for trans-synovial solute transport and a uniaxial solute transport in
an axisymmetric cylinder representing synovial tissue.

1.6 Mechanical Characterization in Tissues
Certain material properties remain unmeasured in synovium including solid volume
fraction, hydraulic permeability, and modulus. Solid volume fraction has been measured in a
multitude of musculoskeletal tissues, relying primarily on a dry weight to wet weight ratio
measurements (Jackson et al. 2008; 2012). Hydraulic permeability is another property that is
well characterized in many tissues, including cartilage, blood vessels and meniscus via fluid
permeation studies (Cocciolone et al. 2018; Kleinhans and Jackson 2018; Armstrong and Mow
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1982; Mansour and Mow 1976). While estimates for elastic modulus of “walls” of the joint space
have been performed from pressure-volume relations (Levick 1987), the modulus of the
synovium remains unknown. Many different techniques have been used to measure the elastic
modulus in other tissues including rheometry, indentation, and stretch/compression tests. A more
complete explanation on mechanical testing will be given in section 4.2.

1.7 Summary
Knowledge of solute transport processes through joint synovium has potential to
significantly impact how we develop therapeutics with increased residence times in the joint to
treat OA and other joint diseases. This dissertation will present studies of solute transport
through the synovium in order to obtain intrinsic parameters regulating transport processes. First,
a computational multiphasic model of trans-synovial transport is established. Second, synovial
explant transport studies are performed and combined with the developed computational model
to estimate effective diffusivities through porcine and human synovium based on molecular
weight. Finally, mechanical testing on explant synovium will be presented to quantify stiffness
and hydraulic permeability needed to model fluid transport in the interstitium accurately.
Overall, the goal of this dissertation is to present, for the first time, tissue-specific parameters
related to transport in synovium that are validated experimentally, and applicable to in vivo
studies towards the goal of understanding the multifaceted aspects of intra-articular drug
clearance.
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Chapter 2: Computational Modelling of
Synovial Transport
Partially adapted from: Guang Y, McGrath TM, Klug NR, Nims RJ, Shih CC, Bayguinov
PO, Guilak F, Pham CTN, Fitzpatrick JAJ, and Setton LA. Combined Experimental Approach
and Finite Element Modeling of Small Molecule Transport Through Joint Synovium to Measure
Effective Diffusivity. Journal of Biomechanical Engineering, 2020, 142(4).

2.1 Abstract
Trans-synovial solute transport plays a critical role in the clearance of intra-articularly
delivered drugs. In this chapter, we present a computational finite element model of solute
transport through the synovium and perform parametric studies to determine key material
properties on mass transport. A multiphasic computational model was constructed and validated
against an analytical solution. Parametric studies of steady-state transport, unsteady transport
through synovium with varying modulus, hydraulic permeability, Poisson’s ratio, solid volume
fraction, effective diffusivity, and starting concentrations were performed. Steady-state
simulations indicated high hydraulic permeability causing deviations from pure Fickian transport
due to high fluid movement. Unsteady transport simulations with high starting concentrations
indicate compaction of the solid matrix restricting transport; at low concentrations, mass
transport is not affected due to fluid movement and is instead dominated by diffusion, with the
effective diffusivity being the main determinant. Additional parametric studies incorporating an
intimal cell layer with varying thickness and varying effective diffusivities were performed,
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revealing a dependence of drug clearance kinetics on both parameters. The predictions of this
model indicate that the predominant material parameter governing solute transport in a
multiphasic mixture model is the effective diffusivity of the solute in the mixture.

2.2 Introduction
The diarthrodial joint consists of two or more articulating bony elements, enclosed by a
synovial membrane that separates the fluid-filled joint space from the surrounding, vascularized
tissue. Pathologies of the joint include rheumatoid arthritis, psoriatic arthritis, osteoarthritis, posttraumatic arthritis, and gout, among others (Cross et al. 2014; United States Bone and Joint
Initiative: The Burden of Musculoskeletal Diseases in the United States (BMUS) 2014). Together,
these arthritides contribute to a high disease burden of disability and pain annually (C. Larsen et
al. 2008; Hootman et al. 2016; Barbour et al. 2017). While systemic delivery of disease-modifying
compounds has demonstrated potential in the treatment of inflammatory pathologies such as
rheumatoid and psoriatic arthritis (Genovese et al. 2005; Elliott et al. 1994), the risk-benefit ratio,
lack of efficacy, and high cost associated with currently available immunomodulatory agents (such
as IL-1 receptor antagonist and anti-TNF) precludes their use in the treatment of single-joint
pathologies such as gout and osteoarthritis (Chevalier and Kemta-Lepka 2010; Jones et al. 2019).
Nonetheless, intra-articular (IA) drug delivery has many advantages over systemic delivery for
treating mono- or oligoarticular arthritides including increased bioavailability at the affected joint,
reduced systemic exposure resulting in fewer side effects, and lower total drug cost (Evans, Kraus,
and Setton 2014; Gerwin, Hops, and Lucke 2006). Short residence times of the injected drug at
the affected joint limit the potential benefits of IA drug delivery (Wallis et al. 1985). Compounds
delivered via IA injection are rapidly cleared through the surrounding synovial membranes (Burt
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et al. 2009; Hui et al. 2012; Revell et al. 1995; Knight and Levick 1984). Recently, drug-containing
microparticles that potentially extend the residence time of the drug in the joint space have been
approved for IA administration in the treatment of knee osteoarthritis (Conaghan et al. 2018; Kraus
et al. 2018). Thus, further understanding of trans-synovial drug transport will guide strategies in
modulating drug size, charge, and availability in the joint space that may lead to improved IA
therapy.
Studies of IA drug transport in animals and humans have been performed using invasive
labels (e.g., radioactive or fluorescent labels) or costly sampling methods (e.g., periodic blood
draws or animal sacrifice) (Sabaratnam et al. 2005; Knight and Levick 1984; Levick 1984). While
these studies revealed an empirical relationship between drug size, disease status, and serum
residence time, the mechanisms that govern mass transport through the synovium are still unclear.
The synovium is a connective tissue of varying thickness, with a superficial intimal layer
containing compacted fibroblast-like synoviocytes (Levick and McDonald 1995; Revell et al.
1995). Underlying the intima is the sub-intima, a connective tissue comprised largely of collagen,
fat and blood and lymphatic vessels (Castor 1960; Smith 2011; Barland, Novikoff, and Hamerman
1962). Drug transport through the intimal and sub-intimal layers is driven by a concentration
gradient between the joint space and the synovial tissue (Simkin and Pizzorno 1974; Simkin 1995)
with many compounds draining out of the joint space via underlying capillaries and lymphatic
vessels (Blewis, Lao, Schumacher, et al. 2010; Price, Levick, and Mason 1996; Bhattaram and
Chandrasekharan 2017). Therapeutic compounds are likely to transport through a number of
distinct and complex, yet still uncharacterized mechanisms. To understand transport processes
occurring within the porous, connective tissue of the synovium, it is necessary to establish the
relative influences of different transport phenomena including passive solute diffusivity through
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the tissue, pressure-driven convective transport, reversible and irreversible binding of compounds
to the extracellular matrix, cell-mediated compound uptake, and lymphatic drainage. Investigating
these phenomena requires fundamental knowledge of synovium porosity or solid volume fraction,
hydraulic permeability to solvent flow, tissue mechanics, and other transport parameters based on
solute-tissue interactions which have not yet been studied in humans or animals.
Several groups have begun to characterize solute transport through the synovium in model
systems. Studies of cell monolayers upon membranes and micro-physiological models of
synovium identified the intima as a size-selective barrier for macromolecules (Blewis, Lao, Jadin,
et al. 2010; Stefani et al. 2018; Blasioli, Matthews, and Kaplan 2014). However, these approaches
did not take into account a role for the extracellular matrix in the sub-intima as a secondary
regulator of solute transport. To this end synovial explant models provide an attractive system to
investigate the role of the sub-intima in regulating mass transport and provide a means to estimate
a solute diffusivity. Sterner and co-workers used customized diffusion chambers to measure
passive diffusion of polyethylene glycol polymers (6-200 kDa) across bovine synovium and found
a correlation between polymer molecular weight and transport speed. Recently Stefani and coworkers assessed the permeability of 70 kDa dextran in bovine synovium explants using a
Transwell® system. While the authors identified differential transport behaviors between native
synovial tissues and an engineered micro-physiological model, intrinsic solute diffusivities within
explant tissues are still unknown (Sterner et al. 2016; Stefani et al. 2018).
The similarities in microstructure between the synovium and other connective tissues,
including cartilaginous tissues, suggest that synovial tissue is best materially described as a
heterogeneous, porous and permeable solid that is fully saturated with an aqueous solvent (Zhu,
Jackson, and Gu 2012; Jackson et al. 2011; Mauck, Hung, and Ateshian 2003; Ateshian et al.
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2004). Models of solute transport developed previously in constructs of cartilage, meniscus, and
intervertebral disc have allowed for explicit representations of tissue porosity, solute diffusivity,
hydraulic permeability, mechanical properties and kinetics of solute-matrix binding, just a subset
of material properties needed to describe the complexity of solute transport in biological tissues.
In this chapter, a computational model of synovium as a porous and fluid-saturated, multi-phasic
mixture was constructed using finite element methodology (FEBio) in order to facilitate modelling
of the experimentally measured one-dimensional transport of solutes through the tissue explant.
Parametric studies varying material properties were performed to determine the effect of each on
solute transport. The goal here is to develop a sample-specific computational model of an
experimental setup for measuring transport properties of solutes of varying molecular weight in
synovium, towards the goal of obtaining an intrinsic material parameter describing diffusivity for
each solute in the studied tissue. Development and validation of such a model will lead the way
for future studies of therapeutic drug diffusion through synovium under healthy and diseased
conditions.

2.3 Materials and Methods
2.3.1 Computational model
Transport was modeled as unsteady, one-dimensional diffusive transport of a solute
through a porous, hydrated tissue layer (Y et al. 1998; Lai, Hou, and Mow 1991). The finite
element code, FEBio, was used to implement a mixture model for synovial tissue with geometric
and material assumptions as previously described (Maas et al. 2012; Ateshian, Maas, and Weiss
2013). Model geometry consisted of a donor fluid bath (1 ml volume) overlaying a fluidsaturated, isotropic and porous tissue layer representing the extracellular matrix of the synovial
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explant (Figure 2.2A). A mesh was created from this model using eight-node hexahedral
elements that were refined closer to the boundary between the synovium and the bath (20
elements each). The synovium was modeled as a multiphasic material with a homogeneous, neoHookean solid phase of uniform hydraulic permeability (k), modulus (E) and Poisson’s ratio (𝜈),
and a solid volume fraction (𝜙𝑠 > 0). The fluid bath was modeled using the multiphasic material
element, but with a porosity of unity (ϕs of 0). Many of the aforementioned values for synovium
are either poorly quantified or not previously measured. Sensitivity studies of solute transport to
these parameters were undertaken by setting a baseline value for each parameter while varying a
single value (Table 2.1). Moduli values for the synovium were set to 105 Pa according to
previously reported measurements with a Poisson’s ratio of 0.4 (Levick 1987). The hydraulic
permeability (k) for synovium was set at 10-8 mm4/µN.s which is an order of magnitude higher
than many other soft tissues (Kleinhans and Jackson 2018). Similarly solid volume fraction was
set at 𝜙𝑆 = 0.19 based on our own estimates.
A model solute was modeled with a free diffusivity (Dfree) of 0.00134 mm2/s (Leaist and
Hao 1994), based on the diffusivity of urea, a small uncharged molecule, which is expected to
diffuse relatively freely through the synovium with no cellular interactions or charge-mediated
binding. Diffusivities in the bath were set to 1000 fold higher to model a well-mixed bath, as has
been done previously (Arbabi et al. 2015; Nims et al. 2015). In this model, the driving
mechanism for solute diffusion is given by the gradient in the electrochemical potential of
solvent phases between the donor bath and the synovium explant. The boundary conditions may
be formulated in terms of an effective fluid pressure (𝑝̃) that is defined as a mechano-chemical
fluid pressure resulting from the hydrostatic fluid pressure (𝑝) and an osmotic contribution due
to the presence of the modeled solute,
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𝑝̃ = 𝑝 + 𝑅𝑇𝐶𝜙

(2.3.1)

In this expression, R is the ideal gas constant and is equal to 8.314 J/mol.K and the
absolute temperature is 310 K. Hydrostatic fluid pressure (𝑝) was assumed to be 0 at equilibrium
with atmosphere, the osmotic coefficient (ɸ) was assumed to be unity in both the fluid baths and
the tissue. Formulation of boundary conditions is then provided in terms of 𝑝̃ to yield a
prediction for C(x,t) as defined below.

2.3.2 Model verification for free diffusion of a solute under steady-state
transport conditions
To validate the FEBio model, computational predictions were compared against those
from the analytical solution for one-dimensional transport of a solute through a dilute bath
governed by Fick’s Law. The analytical solution for solute transport was obtained under
conditions where the solute concentration, C0 is held constant on one face (x=L) and held to be
dilute on the opposite face (x=0).
𝑥

2𝐶

𝜋𝑛

𝜋𝑛 2

−( )
0
𝑛
𝐿
𝐶(𝑥, 𝑡) = C0 𝐿 + ∑∞
𝑛=1 ( 𝜋𝑛 (−1) 𝑠𝑖𝑛 ( 𝐿 𝑥)) 𝑒

𝐷𝑒𝑓𝑓 𝑡

(2.3.2)

Here x is the spatial dimension, t is time, C0 is the concentration of the donor bath, L is
the path length or thickness of the diffusion bath, and Deff is the effective diffusivity for the
solute in the construct. A FE model of a multiphasic tissue layer was set up to simulate this
problem (Figure 2.1A), with the solid volume fraction taken to be ɸs = 0 in order to model a fluid
bath for diffusion. To match Fick’s Law, an effective diffusivity for the model solute (urea) was
taken to be equal to the free diffusivity as Deff = 0.00134 mm2/s in both analytical and
computational models.
31

2.3.3 Steady-state parametric studies of material parameters
Following validation of the FE code, a parametric study was performed to understand the
effect of material properties in the multiphasic implementation. In multiphasic mixture theory,
the presence of a solid and fluid phases can influence solute transport through compaction of the
solid matrix and fluid flow that drags the solute with the flow. These parameters include Young’s
modulus, hydraulic permeability, Poisson’s ratio, and solid-volume fraction. For these studies,
values for a single parameter were varied while the others were held constant. Baseline values
and sweep ranges are found in Table 2.1. Boundary conditions were prescribed as in Section
2.3.2 except that initial concentration of solute on the bath face was 1 M, which is a higher
concentration than any solute be found in synovial fluid, endogenous or exogenous.
Parameter Baseline Value
Modulus (Pa) 105
Hydraulic Permeability (mm4/µN.s)

10-8

Poisson’s Ratio 0.4

Sweep Range
104 - 1010
10-11 - 10-4
0.1 - 0.49

Solid Volume Fraction 0.19

0.1 - 0.99

Effective Diffusivity (mm2/s) 10-3

10-6 – 10-3

Table 2.1 Material properties used in both steady-state and unsteady transport parametric
studies.

2.3.4 Simulation of the unsteady transport problem and parametric Studies
Unsteady transport of the model drug, was modeled through the synovial explant to
simulate the case of IA bolus delivery of a drug. Here, the initial conditions for the donor bath
were defined [C(x=L, t=0) = Cinitial] and the concentration for urea at the sink [C(x=0, t) = 0] was
held constant at 0 for all time; this consistently dilute downstream bath was meant to simulate
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conditions present in a healthy joint where lymphatics drain solutes from the extracellular spaces
under healthy conditions, resulting in rapid clearance of delivered drugs from the joint space.
Transport was simulated over 72 hours with Cinitial = 1000mM or Cinitial = 1mM while varying the
material parameters as in the steady-state case. The effective diffusivity of solute in the
synovium was added as a parameter of interest in the unsteady case for its effect on the clearance
profile (Table 2.1). Effective diffusivity in the fluid bath was set to 1000x the values of effective
diffusivity in the tissue to simulate well-mixed conditions (Ateshian et al. 2014). An additional
study of unsteady transport while varying initial bath concentration was done while holding all
material properties constant to determine effects due to corresponding changes in osmotic
potential. Values for material parameters to minimize solid matrix displacement and fluid flow
were chosen based on these parametric studies.

2.3.5 Parametric studies of Deff in synovial intima
In prior sections, the synovial explant was modeled as a single layer of sub-intimal
connective tissue to readily attain a value for solute diffusivity through the extracellular spaces.
It is important to note, however, that there exists a compacted cell layer similar to a membrane
intima that will vary in composition and thickness. For that reason, a multi-zone model of a
synovial explant (Figure 2.6A) was constructed to estimate the effect of a synovial intima with
lower effective diffusivity (Dintima or Di). The intima was modeled as a layer with thickness Lintima
(or Li= 10 μm) and a total thickness of L=600 μm. Values for Di were varied to be 10%, 1%, and
0.1% of the Deff estimated for sub-intimal tissues from numerical optimization described above.
In a second series of parametric studies, the effects of intimal thickness (Li) were studied by
varying Li=10 μm, 20 μm, 60 μm, and 120 μm for a constant thickness of L= 600 μm and
constant Di to be 10% of Deff.
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2.4 Results
2.4.1 Model verification for free diffusion of a solute under steady-state
transport conditions
Excellent agreement (RSS < 0.001) was obtained between the numerical solution for
steady-state transport of a solute through the construct and the analytical solution given in
equation (2.3.2) (see Figure 2.1B). Following expectations for Fick’s Law governing transport
under these conditions, the equilibrium conditions for solute concentration approached constant
values on both C(x=0) and C(x=L) as shown.
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x/L

Fig 2.1 FEM predictions for the diffusive transport of solute in a fluid bath intended to validate
the finite element model construction in FEBio. (A) FEM mesh showing boundary conditions of
C(x=L, t) = C0 mM and C(x=0, t) = 0 mM. The synovium layer (yellow) is drawn here to denote
coordinate axes and path for diffusion (B) Analytical (solid lines) and FEM (circles) solutions to
the canonical 1-D transient diffusion problem at three representative time points, with the steadystate solution shown at the longest time point. Good agreement between the two solutions
validates the use of FEM as a model of transport between two baths.
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2.4.2 Steady-state parametric studies of material parameters
FEM predictions of model drug concentration (𝐶(𝑥, 𝑡))) , solid matrix displacement
(𝑢𝑥 (𝑥)), net relative fluid flux at the interface between the donor bath and the synovium
(𝜙 𝑤 (𝒗𝑤 − 𝒗𝑠 )), and solute flux (𝐷𝑒𝑓𝑓 (−𝜙 𝑤 𝑔𝑟𝑎𝑑(𝐶) + 𝐷

𝐶
𝑓𝑟𝑒𝑒

𝒘) at the interface between the

donor bath and the synovium were obtained for a range of parametric values as described in
Section 2.3.2. Results are shown in Figures 2.2- 2.5. Concentration, relative fluid flux, and
solute flux were sensitive to values of hydraulic permeability in the 10-8 – 10-4 mm4/µN.s range
(Figure 2.2). While 𝑢𝑥 also varied with hydraulic permeability, the differences in displacements
are on the order of 10-5 mm (10 nm) and thus we conclude that the model predictions for tissue
displacement are relatively insensitive to k. The concentration gradient is sensitive to k (Figure
2.2A) due to fluid flow that results at high values for k (Figure 2.2C), opposing the direction of
solute flow (Figure 2.3D). Net solute flow here is a combination of the conductive Fickian solute
flow and the convective solute flow that is due to entraining the solute with the fluid phase.
Concentration, fluid flux, and solute flux were all insensitive to changes in modulus and
Poisson’s ratio (Figures 2.3 and 2.4 respectively). Displacement was sensitive to moduli in the
104 – 105 Pa range, with displacements on the order of 10-3 mm for E = 104 Pa and 10-4 mm for E
= 105 Pa (Figure 2.2B). While displacements were sensitive to Poisson’s ratio across the range of
values simulated, the differences in displacements are on the order of 10-5 – 10-4 mm (Figure
2.4B).
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In varying solid volume fraction in steady-state simulations, the concentration profile
deviated from the closed form solution baseline (Figure 2.1B) in the extreme cases of 𝜙𝑠 ≥ 0.9
(Figure 2.5A).
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Fig 2.2 Steady-state model parametric sweeps of hydraulic permeability. Plotted are (A)
equilibrium concentration, (B) equilibrium displacement profile, (C) steady-state volumetric
fluid flux at the donor bath tissue interface, and (D) steady-state solute flux at the donor bath
tissue interface. All variables exhibited a dependence on values for the hydraulic permeability as
shown.
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Fig 2.3 Steady-state model parametric sweeps of modulus (E) with output of (A) equilibrium
concentration, (B) equilibrium displacement profile, (C) steady-state volumetric fluid flux at the
donor bath tissue interface, and (D) steady-state solute flux at the donor bath tissue interface.
Only displacement was found to have a significant dependence on modulus.
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Fig 2.4 Steady-state model parametric sweeps of Poisson’s ratio () showing (A) equilibrium
concentration, (B) equilibrium displacement profile, (C) steady-state volumetric fluid flux at the
donor bath tissue interface, and (D) steady-state solute flux at the donor bath tissue interface.
Only displacement exhibited a dependence on Poisson’s ratio with values considered
infinitesimal (~ 10-5) for 𝜈 > 0.45.
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Fig 2.5 Steady-state model parametric sweeps of solid volume fraction. Plotted are (A)
equilibrium concentration, (B) equilibrium displacement profile, (C) steady-state volumetric
fluid flux at the donor bath tissue interface, and (D) steady-state solute flux at the donor bath
tissue interface.
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In the absence of knowledge of these parameters for the synovial tissue, values were
assumed based on these parametric studies to minimize displacement and effects of fluid flow on
concentration gradient. A Poisson’s ratio greater than 0.45 and modulus greater than 105Pa were
selected to minimize the introduction of solid matrix displacement into model optimization to
experimental data (see Chapter 3). Solid volume fraction less than 0.9 and hydraulic permeability
less than 10-8 mm4/µN.s were associated with a negligible impact on the concentration gradient
so that values were chosen for model optimization in that range. Through minimizing
confounding effects of fluid mediated transport and solid deformation, the model is now
parameterized to focus on the study of diffusion.

2.4.5 FE model simulation of unsteady transport and parametric studies
The osmotic potential that drives solute movement from the donor bath to the acceptor
bath also leads to fluid movement from the acceptor bath to the donor bath that can impede
solute transport at sufficiently high potentials. Unsteady transport with an initial concentration of
1000mM showed variability to all parameters studied (Figure 2.6). Modulus values at the low
end of the range contributed to predictions of slower solute clearance from the donor bath over
time, presumably due to elevated values for solid displacement associated with fluid movement.
Values for the modulus of E > 106 Pa contributed to relatively little difference in predicted solute
clearance, similar to findings from the parametric study of steady-state transport (Figure 2.6A).
Simulations for k > 10-6 mm4/µN.s failed to converge; nevertheless, the profiles of solute
concentration in the donor bath over time were relatively insensitive to k in the range of 10-8
mm4/µN.s - 10-6 mm4/µN.s (Figure 2.6B). Below k = 10-8 mm4/µN.s, as k decreases by order of
magnitude, clearance from the bath is enhanced (Figure 2.6B).
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Poisson’s ratio for 𝜈 ≤ 0.3 exhibited no change in the concentration profile, as 𝜈
increases above 0.3 and behavior approaches that of an incompressible material, the profiles
exhibit faster solute clearance from the donor bath, with the profiles for 𝜈 = 0.45 and 𝜈 = 0.49
having very similar donor bath concentration profiles.
Slight changes in the donor bath concentration profiles indicative of decreased clearance
are seen when increasing solid volume fraction from 0.1-0.7, though simulations with volume
fractions above 0.7 failed to converge (Figure 2.6D). Clearance kinetics displayed a high degree
of sensitivity to effective diffusivity, Deff, with complete clearance in the case of 10-3 mm2/s but
not in the cases of below 10-4 mm2/s (Figure 2.6E).
In simulations of an initial bath concentration of 1mM concentration profiles were
insensitive to values of modulus, hydraulic permeability, and Poisson’s ratio (Figure 2.7A, B, C).
With the change in donor bath boundary conditions from a concentration of 1000mM to 1mM,
all simulations in the range of parametric sweeps were able to converge. Similar to the
parametric studies done with a 1000mM donor bath boundary condition, increasing solid volume
fraction led to slower clearance of the donor bath, with the biggest changes seen at 𝜙𝑠 > 0.7
(Figure 2.7D). The effective diffusivity showed the same trend in the 1mM case (Figure 2.7E) as
in the 1000mM case (Figure 2.6E), with decreasing solute clearance as effective diffusivity
decreases.
At baseline, values for the donor bath concentration were insensitive to values for starting
bath concentrations below 100 mM (Figure 2.8A). Thus, the model predictions were found to be
sensitive at baseline to starting solute concentration only in the range of 100-1000 mM. In
selecting values to use for the model, the Poisson’s ratio and hydraulic permeability were set at
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0.45 and 10-9 mm4/µN.s respectively (Table 2.2); this choice was justified as modulus and solid
volume fraction have been previously measured, and effective diffusivity is the chosen
optimization parameter so that it affects clearance irrespective of the concentration boundary
condition. These chosen parameters were shown to minimize the variability in the 100-1000 mM
range (Figure 2.8B)
Parameter Value in Model
Modulus (Pa) 105
Hydraulic Permeability (mm4/µN.s)

10-9

Poisson’s Ratio 0.45
Solid Volume Fraction 0.19
Effective Diffusivity (mm2/s) Optimization parameter
Table 2.2 Material parameters for model optimization to experimental data for studies presented
in Chapter 3, based on the sensitivity studies presented here in Chapter 2.
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Fig 2.6 Model predictions of unsteady transport in the fluid bath with an initial bath
concentration Cinitial = 1000mM while varying (A) modulus (B) hydraulic permeability – 𝑘 >
10−6 mm4/µN.s simulations failed to converge, (C) Poisson’s ratio, (D) solid volume fraction 𝜙𝑠 > 0.7 failed to converge, and (E) effective diffusivity.
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Fig 2.7 Model predictions of unsteady transport in the fluid bath with an initial bath
concentration Cinitial = 1mM while varying (A) modulus (B) hydraulic permeability, (C)
Poisson’s ratio, (D) solid volume fraction, and (E) effective diffusivity. Bath concentration
profiles did not change with modulus, hydraulic permeability, and Poisson’s ratio.
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Fig 2.8 Model predictions of unsteady transport with varying initial concentrations and
corresponding effective fluid pressures for (A) baseline material properties and (B) chosen
material properties (Table 2.2) based on the parametric studies.

2.4.6 Parametric studies of Deff in synovial intima
In the multi-layer FE model of synovium explants, the effective diffusivity in the intimal
layer Di as well as thickness of the intimal layer Li were varied to examine their effects on urea
clearance from the donor bath. Altering DI over three orders of magnitude was associated with
dramatic differences in the time to solute clearance from the donor bath as shown in Figure 3B.
While a ten-fold decrease in Di over Deff produced little effect for an intimal layer of 10 µm
thickness, the time to solute clearance was substantially reduced for the cases when Di = 0.01Deff
and 0.001Deff (Figure 2.9B). In a second parametric variation, increasing the thickness of the
intima with Di = 0.1Deff had the effect of decreasing the kinetics of solute clearance from the
bath (Figure 2.9C).
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Fig 2.9 Model predictions of model drug transport (urea) through a multi-layered synovium
construct in the 1D unsteady diffusion problem. (A) FEM model showing the meshing of two
zones corresponding to sub-intima synovium (yellow) and intimal layer (see inset). Here the
donor bath is also incorporated into the FEM model with dimensions much larger than the 600
μm thick synovium. (B) Effects of intimal diffusivity for urea on donor bath clearance modeled
with a base value for Deff = 3.05*104 mm2/s and a 10 μm thick intimal layer. (C) Effects of
intimal thickness upon donor bath clearance of urea modeled with a base value for (Deff)i =
0.1Deff.
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2.5 Discussion
This study is the first to model synovium mass transport using a multiphasic mixture
model. While cartilage, disc, meniscus, and other connective tissues have been represented using
fluid-solid mixture models, this represents the first time the mixture assumption has been applied
to synovium (Zhu, Jackson, and Gu 2012; Arbabi et al. 2016). The model presented here was
adapted from previous models developed for cartilage and was effective for describing the
analytical solution for steady-state diffusive transport as an approach to validate the FEBio
model development (Mauck, Hung, and Ateshian 2003). In parametric studies of steady-state
mass transport, concentration profiles for the solute deviated from the analytical solution only in
cases of high hydraulic permeability and the limiting case of high solid volume fraction (𝜙𝑠 =
0.99); in general, the concentration profiles were found to be insensitive to parameters of
modulus and Poisson’s ratio. For these simulations, we observed that bulk fluid flow opposes the
direction of solute transport. Significant fluid flow here can drag sufficient solute along with it
such as to diminish the net solute movement (Chahine et al. 2009; Didomenico et al. 2016).
Indeed, in the case of a highly concentrated solute as boundary conditions for mass transport (see
Figure 2.6), the high osmotic potential led to sufficient fluid flow against the solute flow to have
an impact on the solute clearance kinetics. In this case, the results indicate potential compaction
of the solid matrix by which mechanical deformation due to fluid flow restricts the transport of
fluid and mass through the tissue (Ferruzzi et al. 2019; Wiig and Swartz 2012). This effect was
not seen at lower concentrations. In the absence of significant fluid movement, the parameter
with the greatest impact on mass transport was the effective diffusivity. It should be noted that
any fluid flow that would influence solute transport in these models is due entirely to the osmotic
pressure, whereas in vivo there would be hydraulic pressures present within the joint space.
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Furthermore, the hydraulic permeability of synovium has not been previously measure, and thus
for future simulations will be set at values that do not lead to significant fluid movement.
The FE model has the capability to incorporate matrix-solute binding, mechanical
loading, cellular uptake and synthesis, and charge interactions as may be necessary for accurately
modeling the transport of therapeutic drugs (DiDomenico et al. 2017; Didomenico et al. 2016;
Arbabi et al. 2015; 2016; Albro et al. 2016; Nims et al. 2015). Indeed, this FE model-based
approach will be useful for incorporating observed heterogeneities in tissue morphometry and
eventually, tissue composition. Nevertheless, at this point in our understanding of synovium
biomechanics, there is insufficient understanding of coefficients that would govern matrix-solute
binding, cellular uptake and charge interactions, for example, and Chapter 4 of this thesis will
address the previously unstudied role of mechanical loading. Future work will focus on
stratifying the synovium into sub-categories as has been suggested for fibrillar, areolar, and
adipose synovium (Smith 2011) and incorporating heterogeneity in tissue morphometry and
solute diffusivity into the FE model.
The developed FE model of synovium has the potential to predict the effects of varying
molecular weight drugs and their delivery via carrier vehicles and other modifications in future
work. In attempts to increase drug residence times and efficacy, a wide range of drug delivery
depots have been developed to provide for steady and sustained drug release. These depots
include encapsulation of drugs for treating arthritis in microspheres made from natural and
polymeric materials (S. W. Larsen et al. 2011; Betre et al. 2006; Tunçay et al. 2000). The
microspheres have been shown to increase drug residence times in the joint through a transient
microsphere degradation and subsequent drug release, observed as modified transport through
the synovium as well as increased residence of the microspheres themselves due to their large
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molecular weight (Horisawa et al. 2002). By critically identifying the primary transport
mechanisms influencing IA drug clearance, the FE model has the potential to discover optimal
treatment strategies for maximal presentation of therapeutic drug doses within the joint.
Clearance of macromolecules from the joint is known to change with onset of disease
through multiple mechanisms. Pathologic changes in the synovium associated with joint diseases
potentially contribute to the decreased transport including the formation of a pannus-like
structure with increased thickness and cellularity (Shibakawa et al. 2003). The increase in
thickness and altered cellularity may decrease drug transport through the synovium, an issue
further compounded by the formation of a boundary layer of large molecular weight molecules
which leads to a reflectance of the large macromolecules back into the joint fluid (Levick and
Michel 2010). While increased synovial vascularity is associated with joint disease, studies have
shown a corresponding decrease in lymphatic function due to inflammation impeding an ability
for solutes to clear out from synovium (Zhou et al. 2011; Bouta et al. 2015). Additionally, the IA
pressure may be elevated with disease and is another factor to consider when evaluating transport
in pathological drug passage (Levick and McDonald 1995; Scott et al. 2000). A modified version
of the FE model presented here could find value as a predictor of the effects of individual
pathological mechanisms and their anticipated contribution to drug transport.
In this study, parameters were chosen to exclude the possibility for deformation of the
solid matrix, although experimental conditions may allow for solid matrix (Jackson et al. 2008;
Didomenico et al. 2016; Lai, Hou, and Mow 1991; Mauck, Hung, and Ateshian 2003); however,
the material properties pertinent to deformation are poorly characterized in the synovium.
Additionally, the model used in our study makes use of a constant value for the effective
diffusion coefficient, and thus is independent of solute concentration unlike that shown in prior
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studies (Albro et al. 2009). Even with these limitations, this combined computational model is
able to demonstrate the processes of drug transport through synovium.

2.6 Conclusion
The development of this computational model identified effective diffusivity as the main
parameter governing transport. Other material parameters such as modulus and hydraulic
permeability can potentially influence transport given high enough osmotic pressures. Parametric
studies modeling a role for the intima indicate that both intimal thickness and effective
diffusivity are important for transport, but that varying effective diffusivity in both the intimal
and sub-intimal layer will have a profound impact on drug clearance kinetics from the joint
space. Based on the parametric studies performed here, a final set of values (Table 2.2) were
chosen to be used in the following chapters.
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Chapter 3: In Vitro Model of Trans-Synovial
Transport
Partially adapted from: Guang Y, McGrath TM, Klug NR, Nims RJ, Shih CC, Bayguinov PO,
Guilak F, Pham CTN, Fitzpatrick JAJ, and Setton LA. Combined Experimental Approach and
Finite Element Modeling of Small Molecule Transport Through Joint Synovium to Measure
Effective Diffusivity. Journal of Biomechanical Engineering, 2020, 142(4).
And: Guang Y, Davis A, McGrath TM, Pham CTN, Fitzpatrick JAJ, and Setton LA. SizeDependent Effective Diffusivity in Human and Porcine Joint Synovium, in review November
2020.

3.1 Abstract
Intra-articular drug delivery can be effective in targeting a diseased joint but is hampered
by rapid clearance times from the diarthrodial joint. The synovium is a multi-layered tissue that
surrounds the diarthrodial joint and governs molecular transport into and out of the joint. Very
few models of drug clearance of trans-synovial transport exist to quantify diffusivity across
solutes, tissue type and disease pathology. We previously have developed a finite element model
of synovium as a porous, permeable, fluid-filled tissue and used an inverse method to determine
urea's effective diffusivity (Deff) in de-vitalized synovium explants (Guang et al. 2020). This
parameter, Deff, is an intrinsic property that is independent of tissue geometry and samplespecific variables, such as thickness. Here we apply this method to determine Deff from unsteady
diffusive transport of model solutes and confirm the role of molecular weight in solute transport.
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Unsteady transport was well-described by a single exponential transient decay in concentration,
yielding solute half-lives (t1/2) that compared favorably with the intrinsic values for Deff
determined from the finite element model fit. Determined values for Deff parallel prior
observations of size-dependent in vivo drug clearance and provide an intrinsic parameter with
greater ability to resolve size-dependence in vitro. Thus, this work forms the basis for
understanding the influence of size on drug transport in synovium and can guide future studies to
elucidate the role of charge and tissue pathology on the transport of therapeutics in healthy and
pathological human synovium

3.2 Introduction
Arthritis affects more than 50 million patients in the US per year and is projected to
exceed 75 million patients, or 26% of the adult population, by 2040 (Watkins-Castillo 2014).
Systemic delivery of disease modifying treatments for inflammatory arthritis have shown some
promise, although with much poorer efficacy in the treatment of osteoarthritis or gout (Chevalier
and Kemta-Lepka 2010; Jones et al. 2019; Elliott et al. 1994; Genovese et al. 2005). In contrast,
intra-articular (IA) drug delivery of disease-modifying drugs has key advantages over systemic
delivery due to increased drug bioavailability at the affected site, lower drug cost, and reduced
systemic exposure (Evans, Kraus, and Setton 2014; Habib, Saliba, and Nashashibi 2010).
However, these benefits are limited by rapid drug clearance from the joint space, resulting in
short residence times ranging from hours to a few days (Gerwin, Hops, and Lucke 2006; C.
Larsen et al. 2008). Understanding the mechanisms that drive drug clearance from the joint will
better guide the development of effective IA therapies.
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Governing the transport of drugs into and out of the joint is the synovium, a thin, multilayered tissue that surrounds the diarthrodial joint and separates vascular and avascular
compartments. The superficial layer is considered a “leaky” intima, composed of 2 to 3
compacted layers of fibroblast-like synoviocytes (Levick and McDonald 1995). Underneath the
intima, the synovial membrane is composed of connective tissue consisting of collagen, fat, and
blood and lymphatic vessels (Smith 2011; Castor 1960). Transport through the synovium is
driven by an IA hydrostatic pressure and a concentration gradient between the joint space and
synovial tissue. These are regulated largely by extracellular pore spaces and the underlying
capillaries and draining lymphatic vessels (Levick and McDonald 1989).
Much of our knowledge about IA clearance comes from in vivo studies. Historically,
these have been performed using radiolabels, finding a dependence of clearance rate on drug size
and disease state (Page-Thomas et al. 1987; T. Brown, Laurent, and Fraser 1991; Wallis et al.
1985; Owen, Francis, and Roberts 1994). More recent studies in animal models have used near
infra-red (NIR) dyes, fluorescent tags, and magnetic nanoparticles in both osteoarthritic (OA)
and healthy states, finding increased retention in the OA joints as well as differential biodistribution between the two states (Doan et al. 2019; Mwangi et al. 2015; Partain et al. 2020).
However, these studies have been unable to resolve the transport occurring through the synovium
itself. To this end, in vitro systems have been used to investigate trans-synovial transport.
There has been recent interest in studying the transport of molecules through the
synovium using model systems. The earliest of this work was undertaken on fibroblast like
synoviocytes cultured in a monolayer upon membranes to mimic the intima layer, which
demonstrated the potential for synoviocytes to form a size-selective barrier to molecular
transport (Blewis, Lao, Jadin, et al. 2010). Stefani and co-workers expanded upon these studies
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by culturing synoviocytes in Matrigel to form a microphysiological model that corroborated
results from the monolayer studies (Stefani et al. 2019). Similarly, Kiener and co-workers
constructed a three-dimensional model of fibroblast-like synoviocytes in a hydrogel pellet to
demonstrate an ability to replicate the densely compacted intimal layer that regulates molecular
transport in synovium (Kiener et al. 2010). While these studies of cellular systems are useful for
investigating the synovial intima, they fail to consider the role of the underlying sub-intimal
layer and its associated extracellular matrix in modulating drug transport. Some groups have thus
studied diffusion of solutes across synovial explants, including our own work studying transport
in porcine and human explants (Sterner et al. 2016; Guang et al. 2020; Stefani et al. 2019).
Together these studies demonstrate a size-dependent molecular clearance from the synovium, yet
present parameters of transport that are dependent on model geometry and that vary in
dimensions and magnitudes across studies.
The previous chapter (Chapter 2) established a computational model of unsteady drug
transport through synovium. In this chapter, the computational model is optimized to
experimental data using an inverse FE method to determine the effective diffusivity of several
model solutes in synovial explants, towards the goal of elucidating the role of solute size on
governing drug transport through these tissues. The results of this study confirm a role for
molecular weight in governing solute transport in synovium with results that parallel the sizedependent diffusivity measured in in vivo experiments.
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3.3 Materials and Methods
3.3.1 Tissue harvest and preparation
Fresh synovial tissue was collected from three regions of porcine knee joints obtained
within 4 hours of sacrifice. Human samples of synovial tissue were obtained from donor knee
joints through an agreement with the Mid-America Transplant Foundation; tissue was not
evaluated for disease state and the history of pathology of the harvested joint was not known. In
all cases, synovium was procured from three distinct regions adjacent to the lateral femoral
condyle, the medial femoral condyle, and between the femoral condyles on the posterior side of
the femur (Figure 3.1A and 3.1B). Immediately post-collection, explants were cryoprotected by
immersion in 15% sucrose in phosphate buffered saline (PBS) at 4°C (16-24 hours) followed by
soaking in 30% sucrose in PBS at 4°C overnight. To devitalize the tissue, samples were
embedded in low-temperature cutting media (Tissue-PlusTM OCT, Fisher Healthcare, Hampton
NH) and snap-frozen in isopentane (Sigma-Aldrich, St. Louis, MO) cooled by liquid nitrogen.
Frozen explants were stored at -20°C for no less than 48 hours to ensure loss of viable cells. The
frozen blocks were trimmed to less than 1mm in thickness by a sledge microtome (Leica
SM2400, Allendale NJ). Prior to diffusion experiments, samples were thawed at room
temperature and soaked in PBS at 4°C overnight, and the surface area of the samples trimmed to
10mm x 10mm. Thickness across the tissue was measured on a scanning profilometer (Keyence
LJ-V700, Itasca IL) following gentle blotting of the tissue to remove excess liquid.
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Figure 3.1 (a) Porcine and human synovium explants were harvested from medial, lateral, and
posterior regions of the healthy knee joint highlighted by the dashed red lines. (b)
Photomicrograph of knee joint. (c) The FEM mesh used to model explant-specific unsteady
diffusion of solutes at initial concentration C0 across the synovium. (d) Unsteady diffusion
experiment setup. Each explant was secured between donor and sink baths (1 mL each) within a
custom-built diffusion chamber atop a nutating shaker. Solute of concentration C0 was pipetted
into the upstream bath at t=0 to mimic IA bolus drug delivery. PBS was continuously
replenished to maintain dilute downstream conditions.

3.3.2 Unsteady diffusion experiment
The effective diffusivity (Deff) of urea (60 Da, Sigma-Aldrich, n=13/8, porcine/human),
mannitol (200 Da, Boston Bioproducts, Ashland MA, n=9/5, porcine/human) and fluorescently58

labelled dextrans of varying molecular weight (3 kDa, n=6/4, 10kDa, n=8/6, and 70 kDa, 15/8
ThermoFisher Scientific, Waltham MA) were studied in the devitalized synovial explants as
described previously (Guang et al. 2020). In brief, de-vitalized synovial explants were placed
between chambers corresponding to "donor" and "sink" baths (each 1 mL volume of PBS) within
a custom diffusion chamber (Figure 3.1D). At the start of each experiment, a known
concentration of solute (C0) was pipetted into the donor path while a dilute sink bath was
maintained by exchanging the PBS bath at a rate of 2 mL/hour under control of a syringe pump
(New Era Pump Systems NE-300, Farmingdale, NY). Both chambers were held under conditions
of ambient pressure at 37 °C to establish one-dimensional, unsteady diffusion. Solute
concentrations in the donor bath were measured over time by removing 5 μL aliquots at intervals
over 72 hours. Chambers were placed on a 3D nutating shaker (Benchmark Scientific
BiomixerTM, Sayreville NJ) to ensure adequate mixing within the donor bath over time.
For the purposes of this experiment, urea and mannitol concentrations were measured
using colorimetric assay kits according to provided instructions. Dextran concentrations were
measured via fluorescence intensity, with a calibrating curve of known concentrations used to
quantify each measurement (Table 3.1). All concentration measurements were collected using a
multimode plate reader (Perkin-Elmer, Waltham MA). Initial concentrations of solutes were
chosen to ensure detectability in aliquots from between 5-100% of the initial donor bath
concentration.
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Solute Initial Concentration (mg/mL)
Urea 50
Mannitol
3 kDa
Dextran
10 kDa
Dextran
70 kDa
Dextran

Effective Fluid
̃ (Pa)
Pressure 𝒑
-2.06 x 106

Detection

8
0.5

-1.09 x 105
-413

Megazyme D-Mannitol Assay Kit
Texas Red-conjugated

0.25

-61.9

Rhodamine-conjugated

0.25

-8.85

Rhodamine-conjugated

Biosystems Assays QuantiChrom
Urea Assay Kit

Table 3.1 Solute concentrations pipetted into the donor bath at time t=0 and their corresponding
means of detection via plate reader
Desorption of select solutes was evaluated in a subset of tissues after completion of the
diffusion experiment, by suspension in 3x the sample volume of PBS atop a nutating shaker at
37°C for up to 72 hours. The overlying media was then removed to measure solute concentration
as described above.

3.3.3 Measurement of solid volume fraction
Specimens were weighed before and after lyophilization for 48 h to obtain wet weight (𝑊𝑤𝑒𝑡 )
and dry weight (𝑊𝑑𝑟𝑦 ) respectively, for determination of water and solid mass (mw, ms) and a
water volume fraction (𝜙𝑊 ). The intrinsic or true density of the dry lyophilized tissue (𝜌𝑠 )T was
assumed to be 1.42 g/mL (Lees and Heeley 1981) for purposes of this calculation,
𝜙𝑊 = (𝑚

(𝑚𝑤 −𝑚𝑠 )/𝜌𝑊

𝑤 −𝑚𝑠 )/𝜌𝑊 + 𝑚𝑠

(3.3.1)

/(𝜌𝑠 )𝑇
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3.3.4 Modeling optimization to determine effective diffusivity (Deff)
A model was used of synovium tissue as a porous, uncharged and fluid-saturated mixture
as described previously (Guang et al. 2020). Using the finite element software FEBioTM, we
constructed specimen-specific meshes of each tissue studied using eight-node hexahedral
elements that were refined closer to the boundary between the synovium and the bath (Figure
1C) (Maas et al. 2012). The solid phase for each tissue was assumed to be a neo-Hookean solid
with a uniform hydraulic permeability, modulus and Poisson’s ratio. In all cases, a value for the
solid volume fraction 𝜙s of 0.19 was used based on initial measurements of fractional water
weight; the fluid bath was similarly modeled but with 𝜙s of 0. Moduli and hydraulic permeability
values for the synovium were set to fixed values (Table 2.2) chosen to ensure the absence of
deformation in model predictions of ambient pressure (Chapter 2). In this way the transport
characteristics for each solute alone were isolated.
For each solute, an effective fluid pressure (𝑝̃) boundary condition was implemented at
x=0 and initial time (t=0) as,
𝑝̃ = 𝑝 + 𝑅𝑇𝐶𝜙

,

(3.3.2)

where C was matched to the value for concentration of each solute delivered to the donor bath at
time t=0. The hydrostatic fluid pressure (𝑝) was taken to be zero, the osmotic coefficient was
unity, and R and T were the ideal gas constant and absolute temperature, respectively (310 K).
At x=L, where L denotes the maximum tissue depth, the effective fluid pressure (𝑝̃) was taken to
be zero over time representing the dilute conditions of the sink bath. Values for 𝑝̃ used in the
simulation are shown in Table 3.1 for each solute and starting concentration.
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In this problem, the gradient in solute concentration between donor and sink baths drives
an unsteady diffusion of solute through synovium tissue (Figure 3.2). The monotonic decrease in
solute concentration in the donor bath was measured as described above, normalized by starting
concentration (C/C0) and numerically matched to the FEBio predictions of unsteady diffusive
transport over time in order to obtain a single coefficient, the effective diffusivity (Deff). The
effective diffusivity for solute in the model (Deff) was obtained by numerically matching the
concentration measured experimentally in the donor bath against FE model predictions using an
optimization sub-routine supported by FEBio (see Chapter 2?). The module seeks to minimize the
residual sum of squares between predicted and measured urea concentration in the entire donor
bath over time, using a modified Levenberg-Marquardt algorithm (Pujol 2007). Thickness of the
synovium in this FEM simulation was chosen to construct a sample-specific model for each
experimental condition.

3.3.5 Estimation of solute diffusivity in free solution
Solute free diffusivity Dfree (m2/s) was estimated according to the Stokes-Einstein
equation as

𝐷𝑓𝑟𝑒𝑒 =

(3.3.3)

𝑘𝐵 𝑇
,
6𝜋𝑟𝑠 𝜂

where kB is Boltzmann's constant (1.38×10−23 J/K), T is the absolute temperature (310 K), rs is
the solute's hydrodynamic radius (m), and 𝜂 is the solvent dynamic viscosity (kg m−1 s−1) (Miller
and Walker 1924). The viscosity of PBS at 37°C was assumed to match that of water (6.92×10−4
kg m−1s−1).
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3.3.6 Data analysis
Mean values for experimentally measured thicknesses and standard deviations were
determined. Values for goodness-of-fit and Deff were obtained for each solute and each tissue
source in order to calculate mean values and their respective variances. A one-factor ANOVA
was performed to test for differences in Deff across solutes (GraphPad Prism version 8.0.0, La
Jolla, CA) with Tukey’s post-hoc test, separately for human and porcine tissue sources. Using
values for effective diffusivity of urea in porcine tissues of 3.05 +/- 1.26 x 10-4mm2/s, (Guang et
al. 2020) we concluded that a sample size of 6 per solute was sufficient to detect differences in
Deff corresponding to 50% of the mean at a power of 65%. A single-exponential was also fit to
the monotonic decay in C/C0 obtained for each experiment using MATLAB and a time constant
𝐶(𝑡) = 𝐶0 exp(−𝑡⁄𝜏) , 𝜏 ∝ √𝐷𝑒𝑓𝑓 , was obtained. Values of 𝐿2 ⁄𝜏 were plotted against
optimized Deff to check if a single-exponential function could have value in determining Deff.
Finally, optimization determined Deff in porcine samples were plotted against the free
diffusivities estimated for each solute, in order to estimate molecular weight dependence on
deviation from free diffusivity in the system present.

3.4 Results
3.4.1 Measurement of solid volume fraction
Water volume fractions were measured to be ɸw = 0.82 ± 0.0159 (mean ± SD, n = 20) in
porcine samples and an average of 0.81 ± 0.0448 (n = 12) in human samples. For the purposes
of FEM, an average value for ϕs =0.19 was used in all mesh development for ɸw +ɸs = 1. Tissue
swelling was not observed in porcine explants, with thickness after a 72-hour experiment

63

measured to be 94.5 ± 28.5% (mean ± SD) of thickness measured immediately after harvest
(n=5).

3.4.2 Exponential fitting of diffusion experiments
A total of n = 51 porcine and n = 31 human synovial explants were studied in the
diffusion experiments, with measured tissue thicknesses of 632 ± 221 μm and 775 ± 239 μm for
porcine and human, respectively. While every attempt was made to ensure a minimum sample
size of n=6 per solute, challenges to acquiring and preparing human tissues led to our undersampling for mannitol and 3 kDa dextran. The concentration of each solute in the donor bath
decreased monotonically over the course of the diffusion experiments, with corresponding
decreases in the concentration gradient across the tissue (Figure 3.2). Clearance of higher
molecular weight solutes was impaired, when compared to that of solutes less than 3 kDa in size.
First-order exponential fitting described the transient, normalized concentration profiles in the
porcine and human data well (R2 ≥ 0.897), with the exception of the 10 kDa (R2 = 0.749) and 70
kDa (R2 = 0.519) solutes in human explants (Figures 3.3a & 3.3b). From these fits it was shown
that solute t1/2 and 𝜏 in the donor bath generally increase over time with molecular weight (Table
3.2 and 3.3). Statistically significant differences were found in Deff of urea and mannitol when
compared to higher molecular weight solutes ≥ 10 kDa in both porcine and human (p < 0.0001,
one-way ANOVA, Tukey’s post-hoc).
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Figure 3.2 FE predicted concentration profiles across the synovium at 1 hour, 24 hours, and 72
hours for the five solutes studied.
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Figure 3.3 Clearance behavior of urea (60 Da), mannitol (182 Da), Texas Red 3 kDa, D-Rho 10
kDa, and D-Rho 70 kDa from the donor bath. Solute concentrations in the donor bath measured
at each experimental time point, Cbath, were normalized with respect to C0 and plotted with their
fitted exponential decays and representative FEBio predictive curves (RSS < 0.06) for porcine
(a,c) and human (b,d) explants, respectively. Predicted solute clearances from the donor bath
were plotted against data for each solute with residuals < 0.06. Solute half-life in the donor bath
increased with molecular weight for porcine (e) and human (f) samples. Differences in Deff
between lower and higher molecular weights were found for porcine (g) and human (h) samples.
Groups with different letters indicate statistical differences (p < 0.05) between the groups.
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Solute MW
(g/mol)
Urea 60
Mannitol 182
3

Dextran, Texas 3×10
Red
Dextran, 1×104
Rhodamine B
Dextran, 7×104
Rhodamine B

n

L (μm)

t1/2 (h)

Porcine
𝜏 (h)

Deff (mm2/s)

13 593 ± 236

5.01 ± 2.44

7.22 ± 3.52 5.16E-04 ± 2.50E-04

9

723 ± 151

3.79 ± 1.15

3.79 ± 1.15 5.71E-04 ± 1.67E-04

6

656 ± 238

11.9 ± 8.99

17.2 ± 13.0 4.25E-04 ± 3.36E-04

8

654 ± 244

22.8 ± 11.8

32.9 ± 17.0 1.11E-04 ± 5.57E-05

15 587 ± 231

66.7 ± 35.3

96.3 ± 50.9 3.76E-05 ± 2.31E-05

Table 3.2 Tissue thicknesses (L), half-lives (t1/2), exponential time constants (𝜏), and modeldetermined Deff shown as mean ± standard deviation for each solute in porcine synovial explants.

Human
Solute MW
n L (μm)
t1/2 (h)
Deff (mm2/s)
𝜏 (h)
(g/mol)
Urea 60
8 756 ± 143
6.48 ± 2.41 9.35 ± 3.48 4.17E-04 ± 1.40E-04
Mannitol 182
5 754 ± 304
5.92 ± 2.37 8.54 ± 3.42 4.81E-04 ± 2.18E-04
3
Dextran, Texas 3×10
4 813 ± 148
33.5 ± 11.6 48.3 ± 16.8 9.73E-05 ± 2.35E-05
Red
Dextran, 1×104
6 932 ± 324
87.5 ± 58.3 126.2 ± 84.2 5.18E-05 ± 3.36E-05
Rhodamine B
Dextran, 7×104
8 668 ± 229
71.2 ± 27.5 102.7 ± 39.7 3.20E-05 ± 1.25E-05
Rhodamine B
Table 3.3 Tissue thicknesses (L), half-lives (t1/2), exponential time constants (𝜏), and modeldetermined Deff shown as mean ± standard deviation for each solute in human synovial explants.

3.4.3 Computational model predictions of solute behavior
The FEBio predictions of solute transport showed good agreement with data generated by
the unsteady diffusion experiment as measured by nonlinear regression fit statistics of RSS <
0.06 normalized by the initial concentration (Figures 3.3c & 3.3d). Though synovium was
harvested from three distinct regions of the knee joint, no apparent differences were found
between their solute-matched Deff.
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Deff trended downward with increasing molecular weight in porcine (Table 3.2) and
human (Table 3.3) synovial explants. Differences between lower and higher molecular weight
solutes were observed with a cutoff above 3 kDa (p<0.05, one-way ANOVA, Tukey’s post-hoc).
Explant-specific thickness, L, and time constant obtained from exponential fitting, τ, were used
to define a term akin to Deff, 𝐿2 ⁄𝜏. A linear relationship between both terms was found in porcine
(R2 = 0.894) and human (R2 = 0.939) synovium (Figures 3.4a & 3.4b).

Figure 3.4 A linear relationship is observed between explant-specific 𝐿2 ⁄𝜏 and FEM-predicted
Deff for porcine (R2 = 0.894) (a) and human (R2 = 0.939) (b) synovial tissue. Dashed lines indicate
95% confidence intervals.

Further, the difference between each solute's Deff and its known diffusion coefficient in
water, Dfree, was less than one in magnitude (Figure 3.5), showing that the synovium tissue
impeded drug mobility and transport for all solutes. Estimates for Deff in synovium are also of an
order reported in cartilage explants, except for values of molecular weight larger than 3 kDa
(Figure 3.5) (Leddy and Guilak 2003; Torzilli, Grande, and Arduino 1998; Maroudas 1970).
Some of these studies in cartilage used anionic molecules, which would lead to electrostatic
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interactions with the negative charge found in cartilage due to its high glycosaminoglycan
content.

Figure 3.5 FEM-predicted Deff in porcine explants (square), measured Deff in articular cartilage
(Torzilli, Grande, and Arduino 1998; Leddy and Guilak 2003; Maroudas 1970) (triangle), and
Dfree estimated from the Stokes-Einstein equation (circle) plotted for each solute's molecular
weight.

3.5 Discussion
IA drug delivery is inherently an unsteady process as the bolus injection of drug leads to
a period of initial drug distribution within the joint space, followed by drug clearance from the
joint space. Previously we established an experimental-computational approach to analyze the
unsteady clearance of a small neutral molecule, urea, through a porcine or human synovial
explant using a well-mixed diffusion chamber intending to model only unsteady clearance
through the tissue (Guang et al. 2020). By using a finite donor bath and devitalized tissues of
known thickness and surface area, finite element modeling was used to predict the effective
diffusivity of urea, Deff, through the synovium's extracellular space. Here, we used this approach
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to explore the dependence of solute size upon Deff for uncharged solutes in healthy porcine and
human synovium. Model determination of Deff confirmed a dependence of solute diffusivity on
molecular weight for solutes above 1 kDa (p<0.05, one-way ANOVA, Tukey’s post-hoc) that
included all three dextrans studied here. Our results for quantitative parameter determination are
consistent with studies of in vivo transport that demonstrate transport of drugs out of the joint is
impaired for solutes with a molecular weight above the 1kDa – 10kDa range (Mwangi et al.
2018; Doan et al. 2019).
According to a plot of model predictions against 𝐿2 ⁄𝜏, exponential fitting of the model
can also be used as a good predictor of Deff when adjusted for the length scale, L (Figure 3). The
linear relationships found for both porcine and human synovial explants support using first order
exponential decay to model solute clearance from the donor bath with proper knowledge of the
length scale. This makes comparisons across studies of IA clearance difficult as the path length is
often not reported. Without additional knowledge of the geometry of the knee, including
synovial fluid volume and area available to transport, estimating Deff from in vivo data would be
difficult, however, in better characterized systems, such as those used in vitro, with clearly
defined geometries, an estimate could be obtained for Deff.
Further, the linear relation between diffusivities for each solute in free solution and Deff
determined in de-vitalized explant tissues confirms that the tissue restricts solute transport in a
manner consistent across solutes (Figure 3.4). This may indeed be the case for our study of
explants that were free of cell-mediated drug uptake, and free of charge-mediated extracellular
matrix binding. Future modeling studies that account for the interactions between cell and solute,
and matrix and solute, will be important to determine the relative contribution of these factors to
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the kinetics of the unsteady diffusion process and may yield an impaired ability to predict
diffusive transport from a single-exponential decay.
Previous studies have also reported size-dependent solute clearances from the intraarticular space both in vivo and in vitro. Sterner and co-workers approximated the half-lives of
different molecular weight PEG polymers for devitalized bovine synovial explants studied in a
diffusion chamber similar to that described in the present study (Sterner et al. 2016). Rather than
report an effective diffusivity that can be compared to free diffusivities, and diffusivities
measured in other model systems, they record a "retention factor" relative to a small methylene
blue molecule which serves to ratio transport time against that of a standard. While their
observation of a slower permeation speed for larger PEG polymers through synovial explants
agrees qualitatively with our observations for Deff in the present study, our ability to model the
synovium as a porous and permeable solid material permits the determination of an intrinsic
coefficient that can be used to compare diffusivity across other tissues and for solutes in free
solution.
Solute transport has been extensively studied in other porous and hydrated tissues such as
articular cartilage and intervertebral disc. Of relevance here are studies by DiDomenico and
colleagues that compiled effective diffusivities spanning a wide range of molecular weights
collected from more than 50 years of solute transport studies in articular cartilage (Didomenico
and Bonassar 2018; Didomenico, Lintz, and Bonassar 2018). Importantly, the authors note
spherical molecules such as globular proteins, small sugars, and ions, have a lower effective
diffusivity than linear dextrans, which is relevant to our studies of dextrans here. A similar effect
in synovium could explain the lack of strong linear correlation of effective diffusivity with
molecular weight in our study (Figure 3.5), as the spherical urea and mannitol transport
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differently than the linear dextrans. In studying transport in cartilage, multiple models of
cartilage as a hydrogel have been used to predict effective diffusivities based on hydrodynamic
radius and molecular weight of the studied solute (Renkin 1954; Brinkman 1949; Clague and
Phillips 1996). By use of a model of synovium as a porous and fluid-saturated solid, we
incorporate a solid volume that does not enable drug transport in a solution phase. The relative
importance of this solid component will need to be understood through models of diseased
synovium in future work, where both synovial thickness and fibrosus can affect transport.
Joint clearance times for neutral and charged compounds have been tabulated over
decades of work in animal and human studies (C. Larsen et al. 2008). Here we compare recorded
half-lives to those determined using our experimental-computational approach in porcine and
human synovium (Table 3.4).
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Table 3.4 Comparisons of predicted Deff in synovial explants to in vivo IA clearances sorted by
molecular weight (MW) Shaded rows indicate data acquired in the synovial explants in vitro in the
current study.

Solute
24
Na

Urea
I
131 −

MW
Charge
(g/mol)
24 Neutral
60 Neutral
131 Negative

Region of elimination

Reference

(Scholer, Lee, and
Polley 1959)

t1/2 (h)
0.23 Human knee

Canine knee

5.01 Porcine knee explant
0.78 Canine knee
0.57-1.3

Ceftiofur

Mannitol

Positive

963 Neutral

524 Neutral

182 Neutral

11.9 Porcine knee explant

22 Mouse knee

0.92 Rabbit knee

—

—

(Kim et al. 2015)

(Poli et al. 2001)

133 Neutral

Evans Blue

1.01×103

Neutral

22.8 Porcine knee explant

(Simkin and Benedict
1990)

Xe

DiR-loaded PLGA/Eudaragit
RL nanoparticles

3×103

Neutral

12.2 Canine knee

—

133

—
(Simkin and Benedict
1990)
(Phelps, Steele, and
McCarty 1972)

Dextran, Texas Red

1×104

Negative

66.7 Porcine knee explant

—

Dextran, Rhodamine B

6.7×104

Neutral

3.79 Porcine knee explant

I-Albumin

7×104

Negative

21.8-26.3 Rabbit knee

(Coleman et al. 1997)

(Mills et al. 2000)

Dextran, Rhodamine B

~3×106

5.1 Equine
antebrachiocorpal joint

Hyaluronan
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We observed similar trends in both porcine and human synovium for matching solutes,
suggesting porcine synovium is a suitable surrogate for human tissue for trans-synovial transport.
This is in accordance with previous studies establishing porcine joints as an animal model to
study human joint pathologies due to their relatively thick cartilage and limited capacity for
endogenous regeneration (Chu, Szczodry, and Bruno 2010; Cone, Warren, and Fisher 2017).
However, it should be noted that the geometry of the knee, such as synovial surface area and
thickness to synovial fluid volume may differ across species, leading to differences in in vivo
transport times in different animal models (Ritter et al. 2013; Vela et al. 2017). Further, our
approach does not explicitly model an IA pressure, which can be sub-atmospheric in healthy
joints and supra-atmospheric in diseased joints (Levick 1979; Jayson and Dixon 1970).
Explicit modeling of fluid-mediated transport caused by an IA pressure would require
measurement of the hydraulic permeability of the synovial tissue, which was not quantified in
the current study.
In comparing Deff in vitro to the reports for drug clearance in vivo, we note an overall
size-dependent trend in both models. For example, 133Xe clearance from the canine knee is
approximately four times faster than that of ceftiofur (from an equine antebrachiocarpal joint),
which has a larger molecular weight than Xe by approximately four-fold (Phelps, Steele, and
McCarty 1972; Mills et al. 2000). Although such a relationship does not apply for all tabulated
solutes, especially larger molecules, intra-articular half-lives tend to increase with molecular
weight in vivo just as they do for our FE models of synovium based on measurements in vitro.
In general, we observe a greater solute retention in the in vitro explant diffusion studies
than is reported in animal joints in vivo, most apparently for solutes greater than ~500 Da. All of
the approaches for quantifying solute concentration in vivo rely on measurements in collected
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serum or plasma, which has the challenge to measure concentration in a very large diluted
volume. Thus, a living subject’s large blood volume likely causes solute concentration
measurements to fall below limits of detection at very early times following IA injection, a
problem that is not seen in our in vitro measurements. Additionally, active transport mechanisms
in the living subject may oppose solute retention in the synovium. For example, Simkin and coworkers found synovial perfusion hastened the clearance of iodide from the canine joint space,
presumably due to active uptake of iodide from cells within the surrounding tissues. Without
perfusion they reported a significantly lower clearance constant, kelim (0.012 h-1) from the knee
than obtained with blood flow (0.894 h-1) (Simkin and Benedict 1990). Here kelim describes the
fraction of solute cleared from the system per unit time. The former shows greater agreement
with the clearance constants obtained here for devitalized tissue, which are determined by
inverting 𝜏 (Table 3.2 and Table 3.3) and are lacking in the important transport effects induced
by blood flow in tissues adjacent to the joints.
When comparing the experimental-modeling approach we developed here to in vivo
studies it is important to consider the presence of articular cartilage and diffusion of molecules
into cartilage that would extend residence times in vivo, compared to our studies of a synovial
explant. Results from our system yield markedly higher half-lives for solute transport, due in part
to differences in geometry and limits of detection (Table 3. 4). In addition to the model of
synovium presented here, a model incorporating articular cartilage could be developed as
transport of conjugated dextrans have been studied extensively in cartilage (Fetter et al. 2006;
Didomenico, Lintz, and Bonassar 2018; DiDomenico et al. 2017; Leddy and Guilak 2003;
Leddy, Haider, and Guilak 2006; Gardiner et al. 2007; Zhang et al. 2007). One important
parameter for such a model of intra-articular clearance would be the geometry of the joint,
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specifically, the surface area of cartilage, synovium, volume of synovial fluid present, and
effective path length of diffusion in a diarthrodial joint. In the absence of this knowledge, a
representative model would be hard to construct. Further, charged interactions and chargemediated binding in both cartilage and synovium would also impact residence time in the joint;
for the reason that we sought to uncouple charge effects here, this study has focused on
uncharged solutes. Future studies will look at charged solute transport through the synovium, as
FEBio has been used in other applications to incorporate an additional charged species
(Ateshian, Maas, and Weiss 2013). Other limitations of the model exist due in part to lack of
knowledge of synovium material properties relevant to a multiphasic mixture model as has been
previously discussed (Guang et al. 2020). The ability of a multiphasic mixture model to model
solid matrix deformation, fluid movement, and Fickian diffusion makes it more accurate in
representing physical processes present in IA clearance when compared to an exponential decay
model as is commonly reported in IA drug kinetics studies. However, assumptions for values
hydraulic permeability and modulus were made, which are important for fluid mediated
transport, and will be measured in the following chapter.
IA drug delivery has important advantages over systemic delivery, but it has not been
shown to increase the residence time of a therapeutic agent without additional strategies to
increase molecular weight (i.e., crystallization of corticosteroids, PEGylation of protein drugs) or
deliver the drug in a sustained release depot (Evans, Kraus, and Setton 2014). Synovial
lymphatics rapidly clear molecules, restricting residence times of common NSAIDs to only a few
hours. In this work we simulated this drainage by maintaining dilute downstream conditions in
custom-built diffusion chambers representing theoretically complete lymphatic clearance.
However, several studies have indicated reduced lymphatic drainage in the arthritic knee, altered
76

lymphatic vessel distribution, and increased synovial thickness and IA pressure (Liang et al.
2016; Guo et al. 2009; H. Xu et al. 2003; Gaffney et al. 1995; Jayson and Dixon 1970; Smith
2011). Future modifications to the FE model will aid in an ability to model these pathological
contributions of increased synovium thickness, IA pressure, and increased cellularity, as well as
provide for the inclusion of charged solute-matrix interactions. The current study demonstrates
that transport in synovium can be modeled with the tissue as a porous and permeable, fluid-filled
solid that in future studies will serve as prerequisite for incorporating more complex features,
which invariably accompany pathologic changes.

3.6 Conclusion
The combined experimental and computational approach used here confirms the utility of
a multi-phasic model of synovium to study passive transport processes through the tissue layer.
The model used here enables determination of an intrinsic diffusivity that predicts a dependence
on solute size and parallels previous reports for solute size dependence of drug clearance from
the joint space in vivo. We observed a strong linear relationship between Deff and t1/2 when
normalized by the square of thickness L, indicating the important role of geometry in studies of
synovial transport. Further, we did not observe any differences in transport times between
porcine and human synovium, supporting the use of porcine tissue as a model of transport. The
data from the current model and study forms the basis for understanding the specific contribution
of molecular size, which are prerequisite to understanding the impact of charge, active transport,
intra-articular pressure and changes associated with pathology that will be important in
predicting the transport characteristics of therapeutic drugs in models of healthy and pathological
human synovium.
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Chapter 4: Mechanical Testing of Joint
Synovium
4.1 Abstract
Multiphasic models were previously developed to predict solute transport in human and
porcine synovium, and demonstrated an explicit dependence on the hydraulic permeability,
controlling fluid movement, and measures of mechanical stiffness including compressive
modulus and Poisson’s ratio. Here we obtain direct measures of the hydraulic permeability and
compressive modulus from confined compression stress-relaxation testing of human and porcine
synovium. A compressive aggregate modulus for the solid phase was quantified from linear
regression of the equilibrium compressive stress upon strain (HA = 4.00 kPa, 95% CI 2.97 – 5.04
kPa porcine; HA = 4.27 kPa, 95% CI 1.34 -7.19 kPa, human). An FE model of the uniaxial
compressive stress-relaxation response to a compressive strain ramp and hold was used to
optimize experimental measures of compressive stress to determine a constant hydraulic
permeability (k = 6.19E-19 m4/N.s, 95% CI 5.05E-19 – 7.33E-19 m4/N.s, porcine; k = 7.23E-19
m4/N.s, 95% CI 5.52E-19 – 8.95E-19 m4/N.s, human). Optimized FE models were unable to
fully describe the stress-relaxation behavior, indicating the assumption of linear compressive
stress-strain and constant permeability values may be insufficient for synovium. Modulus values
measured here are similar to values measured using atomic force microscopy in a recent
conference proceeding (Gangi et al. 2021). The values for material constants determined from
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this study can be used to refine the transport models previously developed and bring us closer to
building models that predict solute clearance in healthy and pathological joints.

4.2. Introduction
The transport of fluid and solutes through joint synovium is essential to the health of the
tissue, as well as the regulation of synovial fluid homeostasis and fluid mediated transport
(Knight and Levick 1984; Walsh et al. 2012; Ropes, Rossmeisl, and Bauer 1940). In prior
studies, solute transport through synovium was determined from experimental studies of solute
transport and a computational model of solute transport (Chapters 2 and 3). This model
represented tissues as porous and permeable, and saturated by two fluid phases – a solute phase
capable of gradient-induced solute flow – and a fluid-phase (water) subject to pressure-induced
fluid movement. Predictions suggest that fluid movement entrains solute movement, and solute
movement can similarly promote fluid movement in order to balance an induced osmotic
gradient. For this reason, parameters governing fluid movement in the synovium are necessary
to accurately determine the transport of solute in healthy and pathological joints.
In hydrated soft tissues, fluid transport is governed by the material property of hydraulic
permeability as has been shown in other joint tissues such as meniscus and articular cartilage
(Lai and Mow 1980; Gu, Lai, and Mow 1993; Mow et al. 1980). The hydraulic permeability is a
measure of how readily fluid moves through the pore spaces of the tissue. Permeability in transsynovial transport often refers to the bulk transport of solutes through the synovium, a process
that involves both diffusive and convective transport, and is also a quantity that depends on the
geometry of the synovium (e.g. thickness) (Kushner and Somerville 1971; Levick 1981; Levick
and McDonald 1989). Thus, isolating the fluid transport through synovium by quantifying the
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hydraulic permeability can provide important insights into the process of fluid mediated solute
transport in the joint.
Composition and mechanical functions are closely linked in many hydrated tissues. The
extracellular matrix (ECM) of the synovium is dominated by the composition of the subintimal
layer, which consists of primarily type I fibrillar collagen and glycosaminoglycans (GAGs) such
as hyaluronan, chondroitin sulphates, and heparin sulphates (Smith 2011). This type of matrix is
similar to articular cartilage, which exhibits biphasic properties due the hydrating effect of GAGs
(Mow et al. 2002); however the exact composition of these GAGs in synovium has been shown
to be quite different from that of cartilage, with lower concentrations of chondroitin sulfates and
higher concentrations of heparin sulphates (Price, Levick, and Mason 1996). The GAGs present
in the synovium ECM, specifically hyaluronan and chondroitin sulphate, are thought to be major
contributors to the high hydraulic resistance observed in synovium necessary to retain the
synovial fluid within the joint (Scott et al. 1997). Lining the joint space and dispersed throughout
the synovial subintima are mechanosensitive fibroblast like synoviocytes responsible for
producing the hyaluronan and lubricin in synovial fluid and maintaining ECM constituents
(Estell et al. 2017). There are few tissues sufficiently similar to suggest what might be the
compressive and fluid-transport properties of synovium based on these matrix constituents.
Nevertheless, the tissue structure and composition bear similarities to other porous, fluid-filled,
and deformable connective tissues such as cartilage, meniscus and annulus fibrosus.
The mechanical properties of articular cartilage, meniscus, ligament, and cornea have
been mechanically described as a biphasic material (Athanasiou and Natoli 2008). The
compressive behavior of these tissues is well studied using biphasic theory in confined
compression, with established experimental methods (Ateshian et al. 1997; Johannessen and
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Elliott 2005; Mow et al. 1980; Fithian, Kelly, and Mow 1990). Within compression testing of
mechanical test samples, there are a multitude of testing modalities that may be used including
ramp, stress-relaxation, creep, indentation, and dynamic testing. To date, the only reported
mechanical testing in synovium has been tapping-force mode atomic force microscopy to
estimate the modulus (Gangi et al. 2021). In the mechanical testing of soft tissue samples, a
commonly used approach is compressive stress-relaxation testing in a fluid bath to retain
hydration of the fluid phase. In a series of strain steps is applied to the sample, each ramp
followed by a hold at a constant strain for a set period of time. The force at the end of the hold is
recorded as the equilibrium force which can be used to calculate an equilibrium stress combined
with the cross-sectional area. Stress-relaxation tests are commonly combined with confined
compression where the tissue sample is placed into a chamber to prevent deformation in any
direction not along the axis of the tester. A porous actuator or base is integrated into the test
setup in order to allow for unidirectional fluid flow out of the tissue as it is being compressed
(Patel et al. 2019). The stress-relaxation behavior of tissues can be described with a poroelastic
model, which is typically linear biphasic, to obtain both an aggregate modulus and hydraulic
permeability (Park et al. 2003; Mak, Lai, and Mow 1987). Through use of a confined
compression stress-relaxation test, the synovium can be characterized as a biphasic material in
order to be integrated into a triphasic/multiphasic model of drug transport to evaluate the effects
of fluid transport on IA drug clearance.
The compressive modulus of the synovium is particularly interesting because of the
possibility of compaction of the solid matrix, a process by which deformation of the solid matrix
can alter tissue solid volume fraction and hence permeability to fluid-flow, which could
contribute to the high hydraulic resistance previously observed (Holmes 1986; Scott et al. 1997).
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In Chapter 3 modeling, we relied upon an assumed value for the tissue permeability to fluid-flow
and to compressive deformation, chosen to insure minimal fluid movement and solid
displacement, as determined by the parametric studies in Chapter 2. Here we implement a
combined experimental-computational approach to determine the compressive modulus and
hydraulic permeability for porcine and human synovium.
The goal in this study was to directly measure the biphasic properties of joint synovium
in a confined compression experiment. The experiment was combined with a biphasic finite
element model to match the experimentally measured data. This approach was able to quantify,
for the first time, values for compressive modulus and hydraulic permeability that can be used in
models of healthy and diseased synovium to accurately predict solid matrix and fluid behavior.

4.3 Materials and Methods
4.3.1 Tissue harvest and preparation
Porcine (n=20) and human (n=12) synovial tissue samples were collected and frozen as
previously described from three distinct anatomic regions (Section 3.3.1). Following freezing,
the frozen blocks were trimmed to using a sledge microtome to create an even surface from the
subintimal side (Leica SM2400, Allendale NJ). Samples were then thawed at room temperature
and held in PBS at 4°C overnight to allow for hydration and were then biopsied into cylindrical
plugs using a 1/4 inch cutting punch (McMaster-Carr 9611K12).
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4.3.2 Confined compression testing
a

Confining Ring

b

Actuator
Platen
Confining Ring

Platen

Porous Platen

Tissue

Bath

Porous Platen

PBS Bath

Load Cell

Fluid flow

Figure 4.1 a) Schematic of confined compression chamber b) photomicrograph of the testing
configurations with inset showing a tissue plug
Synovial tissue plugs were tested in a custom-built apparatus in confined compression
under displacement control using a mechanical test instrument with a 45N load cell (TA
Instruments ElectroForce 3200, New Castle DE). The apparatus consists of a radially confining
chamber ¼ inch diameter (6.35mm) atop a porous steel platen to provide support to the tissue
and interface with the load cell (McMaster-Carr 9446T31, 40 micron pore size). An impervious
aluminum platen (1/4” diameter) is placed in line with the actuator and allowed to come into
contact with the tissue during testing. During testing, the chamber and its surroundings were
filled with PBS to allow for fluid exchange (Figure 4.1). Prior to placing the tissue samples
within the test chamber, the position of the porous steel platen insert was recorded under a tare
load of 1 N. The platen was then retracted and the tissue plug was loaded into the confining
cylinder and seated using three sequential tare-loads of 0.1N separated by 100s; the difference
between the position of the platen following the pre-load and the position for the platen was
taken to be the tissue thickness. Following the pre-load sequence, a cyclical wave-form of 1%
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strain was applied at 0.1 Hz for 200s and held at 1% strain for 800s to seat the sample. A stressrelaxation test was then begun by applying a compressive displacement to the sample in the form
of five consecutive linear ramp displacements to 2% strain at a rate of 0.01% strain/s ;
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displacements were held while the load cell recorded the force decay for an 800s period (Figure
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Figure 4.2 Representative stress-relaxation compressive stress (blue) and strain (red) data for
a) porcine and b) human synovium in confined compression showing the five successive
ramp and hold wave forms. Green dots represents the equilibrium stress, corresponding to the
last 40s of the hold period of the last four holds (2%-10% strain).
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4.2). The stress acting on the tissue was calculated as the measured force divided by the crosssectional area of the specimen (31.7 mm2).
The compressive aggregate modulus (𝐻𝑎 ) is a measure of the apparent compressive
stiffness of the synovium in uniaxial compression, where lateral expansion of the tissue was
prevented by the radial confining walls. The compressive modulus was determined by linear
regression of the equilibrium stress (i.e., last 40s of the 800s hold period of the last four holds)
upon the calculated strains over increments from 4-8% strain. The last four holds were used to
eliminate any artifacts due to improper seating of the sample that led to inaccurate measurements
of force in the first waveform.

4.3.3 Biphasic computational model
a

b

Figure 4.3 a) a representative mesh of the rigid body (yellow) and the tissue plug (orange) b)
a 3o wedge of the tissue plug meshed using circumferential symmetry to reduce number of
total elements and computational intensity. Lines within the tissue and the rigid body indicate
mesh lines.
A biphasic computational FE model of the confined compression test was created to
estimate the hydraulic permeability in FEBio. The synovium geometry was modeled as a
cylinder with a radius of 3.175mm and height matched to experimentally measured data (Figure
4.3a). Assuming circumferential symmetry, a 3o wedge of the cross-sectional area was meshed as
shown in Figure 4.3b using 20 hexahedral ? elements in the z-direction that were refined closer
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to the top and bottom platens. The actuator was modeled here using a rigid body element at the
top face of the tissue (Figure 4.3b). The solid phase for the synovium was represented as an
isotropic, neo-Hookean solid with uniform Young’s modulus (E) and Poisson’s ratio (𝜈) and
with a constant isotropic hydraulic permeability (k). Young’s modulus was calculated on a per
specimen basis from 𝐻𝑎 , as determined by

𝐻𝑎 =

𝐸(1 − 𝜈)
(1 + 𝜈)(1 − 2𝜈)

(4.1)

Poisson’s ratio has not been previously measured in synovium and was assumed to be 0.2 as
based on values from articular cartilage (Boschetti et al. 2004). Displacement was restricted in
the x- and y- directions along the circumference, while z-displacement was constrained at the
interface with the impermeable platen. Effective fluid pressure at the porous platen was set at 0
Pa to allow for fluid to move out of the hydrated tissue. A single ramp and hold waveform was
modeled here by prescribing a displacement of the rigid body of 2% strain over 200 s (0.01%
strain/s) followed by a boundary condition of holding at the 2% strain over 800s.

4.3.4 Modeling optimization to determine hydraulic permeability
The hydraulic permeability for the tissue in the model (k) was obtained by numerically
matching the force measured experimentally with FE model predictions of force acting on the
rigid body using an optimization sub-routine supported by FEBio. The last ramp and hold
waveform was chosen for each experiment, corresponding to 8 or 10% strain, as input data for
the optimization module and filtered using a moving average filter with a window of 20s. The
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module seeks to minimize the residual sum of squares (RSS) between predicted and measured
force values, using a modified Levenberg-Marquardt algorithm (Pujol 2007).

4.3.5 Data analysis
Comparisons between human and porcine synovial tissue were done in GraphPad Prism
using a student’s t-test with a level of significance at p<0.05. Power analysis indicated an
inability of the sample size to detect differences between anatomic regions for both modulus and
permeability, as well as between species.
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4.4 Results

Figure 4.4 Representative stress-strain data with linear fits for a) porcine (n=20) and b)
human (n=12) synovium c) Calculated equilibrium modulus values with mean and 95%
confidence intervals.

4.4.1 Confined compression modulus
Stress-relaxation behavior was observed as a peak stress followed by a monotonic decay
to an equilibrium value in all samples (Figure 4.2). A linear model of the compressive aggregate
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modulus fit the data well with an average coefficient of determination R2 of 0.806 and 0.858 for
porcine and human synovium respectively (Figure 4.4a and b). Equilibrium modulus for human
and porcine synovium was found to be 4.27 kPa (95% CI 1.34 – 7.19 kPa) and 4.00 kPa (95% CI
2.97 – 5.04 kPA) respectively with no differences found between the two (Figure 4.4c).

Figure 4.5 Representative optimization of FE model force to filtered experimental data for
the last hold (8-10% strain) for a) porcine (k=5.76E-19 m4/N.s, RSS = 0.0150 N2) and b)
human (k=5.41E-19 m4/N.s, RSS = 0.00844 N2) synovium c) Optimized hydraulic
permeability values with mean and 95% confidence intervals.

4.4.2 Computational model predictions of stress-relaxation
The computational FE model was able to model stress-relaxation of the synovium
moderately well with average RSS = 0.0159 N2 and 0.0127 N2 for porcine and human synovium
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respectively, with the model best matching experimental data during the ramp portion of the
stress-relaxation curve. The model was unable to fully capture the peak force and exhibited a
faster stress-relaxation following the peak than was measured experimentally. Further, the
predicted data consistently under predicted the relaxation force at the end of the hold period;
larger residuals reflected the inability to accurately predict the hold portion as opposed to the
ramp portion (Figure 4.5a and b). No difference was found between values of permeability for
porcine (Mean 6.19E-19 m4/N.s, 95% CI 5.05E-19 – 7.33E-19 m4/N.s) and human (Mean 7.23E19 m4/N.s, 95% CI 5.52E-19 – 8.95E-19 m4/N.s) synovium. A summary of the mechanical
properties from curve fitting to the equilibrium stress-strain curve and from optimization to
experimental stress-relaxation data can be found in Table 4.1
k (* 10-19 m4/N.s)

HA (kPa)
n

Mean

95% CI

Mean

95% CI

Porcine

20

4.00

2.97-5.04

6.19

5.05-7.33

Human

12

4.27

1.34-7.19

7.23

5.52-8.95

Table 4.1 Summary of biphasic mechanical data with 95% confidence intervals. No differences
between species were found for either property.

4.5 Discussion
Stress-relaxation confined compression experiments combined with a biphasic model in
FEBio were used to determine an equilibrium modulus and hydraulic permeability for porcine
and human synovium here. No differences in modulus nor hydraulic permeability were observed
between human and porcine synovium, similar to the lack of difference in solute transport found
previously (Chapter 3), providing further evidence that pig synovium is a good surrogate for
human synovium. A recent conference abstract presented by Gangi and co-workers reported
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compressive modulus of bovine and human synovium using AFM testing, and reported values in
the 1-10 kPa range similar to data shown here from confined compression (Gangi et al. 2021).
Values estimated for hydraulic permeability in synovium were orders of magnitude lower than
other joint tissues, and lower than other soft hydrated tissues (Table 4.2). The very low hydraulic
permeability agrees with prior assessments of a high hydraulic resistance necessary to sequester
synovial fluid to the joint space (Scott et al. 1997).
Testing Method

HA or E (kPa)

k (m4/N.s)

Ref

Nucleus Pulposus Bovine
(nondegenerate)

Confined
Compression

HA = 1,010

9.00E-16

(Johannessen and
Elliott 2005)

Nucleus Pulposus Bovine
(degenerate)

Confined
Compression

HA = 440

1.45E-15

(Johannessen and
Elliott 2005)

Articular Bovine
Cartilage
(Glenoid)

Confined
Compression

HA = 400

2.7E-15

(Ateshian et al. 1997)

Indentation

HA = 606

1.4E-15

(Athanasiou et al.
1991)

Vitreous Humor Bovine

Confined
Compression

-

8.4E-11

(J. Xu et al. 2000)

Vitreous Humor Porcine

Capillary
Rheometry

E = 0.0573

-

(Swindle, Hamilton,
and Ravi 2008)

Sclera Porcine

Unconfined
Compression

HA = 10

1.4E-14

(D. M. Brown,
Pardue, and Ross
Ethier n.d.)

Brain Rat

Indentation

E = 0.04 - 18.2

1.2E-13 –
5.5E-13

(Wang and
Sarntinoranont 2019)

Confined
Compression

E = 10.3

-

(Gefen and
Haberman 2007)

Meniscus Porcine

Direct
Permeation

-

1.53E-15 –
1.87E-15

(Kleinhans and
Jackson 2018)

Synovium Bovine

AFM

E = 1-10

-

(Gangi et al. 2021)

Tissue Species

Articular Human
Cartilage (femorotrochlear)

Adipose Tissue Sheep
(Gluteus)

Table 4.2 Comparisons of compressive stiffness as aggregate modulus (HA) or Young’s modulus
(E) and hydraulic permeabilities from other mechanical tests of soft tissues.
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Moduli were well-determined by a linear fit to compressive stress-strain data from 4-10%
(R2 = 0.806 and 0.858) indicative that our assumption of a linear modulus was appropriate at the
strain levels. When fitting the FE model to the data the constant compressive modulus
determined experimentally, the model was able to predict the behavior of the ramp phase well
with a consistent overshoot of the peak force, but was unable to capture the hold portion of the
waveforms, with the force decaying quicker than in the experimental data, and often under
predicting the equilibrium force. This could be due in part to our use of the linear assumption and
experimentally determined modulus as it is evident that the data demonstrated an apparent
stiffening with increasing strain (i.e., non-linear modulus). Further, the assumptions of a
constant permeability value for all magnitudes of strain over the 8-10% range may have led to a
poor quality-of-fit. Non-linear strain-dependent permeability could explain the lack of agreement
between the model and the experimental data; the use of this assumption here suggests that the
lower values of permeability are determined by optimization to overcome the actual decrease in
permeability due to compressive strain and compaction of the solid matrix (Holmes 1986). The
work here forms a basis for further work of incorporating strain-dependent permeabilities and
non-linear stress-strain behavior in the synovium. Small strain magnitudes and slow ramp rates
used here were used to minimize local tissue strains to best match the assumptions made in
infinitesimal strain theory and subsequently mixture theory (Athanasiou and Natoli 2008).
Further there is no evidence synovium is experiencing through-plane compression in situ greater
than the 10% strain chosen here, as the synovium is not a load-bearing tissue.
Although this study is the first to report values of hydraulic permeability, and one of the
few to estimate stiffness, there are many limitations. Equilibrium modulus estimated from a
confined compression test can measure the modulus in the through-plane direction, which is not
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representative of synovium in a joint that stretches and folds along the planar direction as the
joint articulates. However, the confined compression stress-relaxation test used here has been
used to measure biphasic mechanical properties in many other hydrated tissues. Given the low
modulus measured here, the maximum force for a given test only reached about 3% of the
maximum allowable force for the 45N load cell, leading to poor resolution of roce and increased
noise to accurately capture the compressive force response; there is not evidence, however, that
greater force resolution would have overcome the limitations of poor qualities of fit to the
experimental data.
The porcine synovial tissues used here were all healthy, while the disease state of the
human tissues were unknown, thus the values here are only applicable to non-disease states. In
joint diseases such as osteoarthritis, one of the major changes associated with synovitis is the
thickening of the membrane (Wenham and Conaghan 2010). In arthritis, matrix
metalloproteinases are released in the inflammatory response, which degrade ECM components
including the GAGs thought to be responsible for the low hydraulic permeability in synovium
(Burrage, Mix, and Brinckerhoff 2006). The loss of GAGs may lead to an increase in the
permeability, however, the thickening of the synovium would counteract that loss to maintain
hydraulic resistance. Furthermore, diseased joints have been found to have higher resting values
of IA pressure from the subatmospheric pressures in a healthy joint, and indeed reverse the
pressure gradient (Rutherford 2014). The suprastmospheric pressure drives fluid out of the joint
in pathology, which would reduce residence time, ignoring other pathologic changes to the joint,
due to the fluid mediated transport. Based on these initial estimates of hydraulic permeability, an
estimate for the degree of fluid mediated transport in IA drug delivery could be obtained,
however these values are for non-pathologic tissue.
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The values of modulus and permeability of porcine and human synovium experimentally
measured here can be used to refine previous estimates of model solute diffusivity through
synovium as presented in Chapter 3. The modulus measured here is approximately two orders of
magnitude lower that average values used for measures of diffusivity in Chapter 3; similarly, the
hydraulic permeability measured here is approximately four orders of magnitude lower than that
assumed in Chapter 3; thus the tissue is more easily deformable as determined from experiments,
but fluid is less able to flow through the mixture. Preliminary studies using these new values
indicate minimal changes in diffusivity values (data not shown), suggesting that the assumption
of little bulk fluid movement through the synovium under experimental conditions was valid, and
the values chosen based on the parametric studies in Chapter 2 were accurate.
Parameter Values Assumed in
Chapter 3
Modulus (Pa) 1E5
Hydraulic Permeability
(m4/N.s)

1E-15

Measured Porcine
Values

Measured
Human Values

4.00E3

4.27E3

6.19E-19

7.23E-19

Table 4.3 Values of modulus and hydraulic permeability used in Chapter 3 and values to be used
to refine the diffusivity estimates.

4.6 Conclusion
The findings of this study demonstrate applicability of a confined compression test
analyzed using biphasic mixture theory implemented in FEBio to characterize synovium
mechanical properties. The values presents here represent the first reported values for aggregate
modulus and hydraulic permeability, which was found to be orders of magnitude below known
values of permeability in other tissues. The work here better informs future studies that can
incorporate more complex material models of the synovium including strain-dependent
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permeabilities, tissue viscoelasticity, and stress-strain nonlinear behaviors. Overall, directly
measuring the mechanical properties of the synovium will improve efforts of modeling joint
synovium using both tissue engineered and computational methods that are capable of predicting
solute transport in healthy and pathological synovium.
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Chapter 5: Conclusions and Future
Directions
IA drug clearance is a multi-step process through which the bolus injection will distribute
within the IA joint space, diffuse through the synovium, and clear out of the joint area through
vessels. Previous studies in IA drug transport have evaluated this process as a bulk parameter,
lacking the ability to study the process in its individual components.
The work detailed in this dissertation evaluates the trans-synovial transport properties.
First a computational multiphasic model of solute transport was developed of the synovium,
identifying key material properties intrinsic to the tissue governing transport. This computational
model was then combined with an experimental protocol studying the role of molecular weight
on solute transport to obtain effective diffusivities in the synovium. Finally, hydraulic
permeability and modulus of the synovium was quantified in mechanical testing towards
developing a model of transport that can accurately describe fluid movement and fluid mediated
molecular transport.
In chapter 2, the finite element package FEBio was used to model transport across
synovial tissue using multiphasic mixture theory. The software package was validated against a
closed-form steady-state solution prior to building a model of a bolus drug delivery and unsteady
transport. Parametric studies of multiphasic material properties in unsteady transport identified
effective diffusivity as the major determinant of solute clearance times. Under specific
conditions of a highly deformable and very fluid permeable material, modulus and hydraulic
permeability were shown to influence solute clearance due to compaction and fluid mediated
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transport. Further parametric studies of a heterogeneous synovium with layers representing the
intima and sub-intima revealed thickness and effective diffusivity in the layers as important
factors in the drug clearance kinetics. Lacking a priori knowledge on many material properties of
the synovium, the parametric studies used here informed selection of modulus and hydraulic
permeability leading to no fluid mediated transport, while effective diffusivity was chosen as the
optimization parameter for numerical matching to experimental data in chapter 3.
To further our understanding of the role of molecular weight on transport through the
synovium, chapter 3 outlines an experimental model of transport, which combined with the
computational model from chapter 2, is able to estimate, for the first time, effective diffusion
coefficients through the synovium based on molecular weight. The experimental setup mimicked
unsteady transport of uncharged solutes of varying molecular weights in the joint space through
porcine and human synovium and showed a similar relationship between size and clearance
times as studies done in vivo. Calculated time constant from a first order exponential fit to
experimental data correlated well with effective diffusivities from the computational model after
controlling for thickness, emphasizing the importance of system geometry, and the potential of
using in vitro models to predict in vivo transport times. Additionally, similar trends between
porcine and human synovium here suggest porcine synovium as a suitable surrogate for human
tissue in studies of trans-synovial transport. The intrinsic diffusivity presented in this chapter is
independent of the system, unlike previous in vitro studies which calculated parameters that
depend on the system geometry (i.e. thickness of tissue, volume of bath, area of diffusion).
Chapter 4 presents mechanical testing of joint synovium in a confined compression
stress-relaxation experiment to measure biphasic properties of the synovium for the first time.
Modulus was estimated directly from the equilibrium stresses measured, while a linear isotropic
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biphasic FE model was used to numerically match experimental transient data for stressrelaxation to obtain values for hydraulic permeability, in an approach similar to Chapter 3. The
model was unable to accurately fit the entirety of a stress-relaxation increment, indicating the
assumption of a linear biphasic material may be unable to describe the behavior of this synovial
tissue. However, this study is the first of its kind to apply biphasic theory to synovial tissue or to
provide data for the stress-relaxation behavior of synovium; more data in mechanical testing is
necessary to confirm the use of biphasic theory as appropriate for describing the mechanical
properties of synovium. Future work incorporating added model complexity, that may include
strain-dependent permeabilities and nonlinear stress-strain behaviors, may help improve the
model predictions of the experimental data.
In addition, the biphasic model as used here in compression stress-relaxation testing
estimates the permeability of synovial tissue indirectly from the transient stress response to
deformation. An alternative method could be used to measure permeability such as a direct
permeation experiment which measures fluid that has moved across the tissue.
The aggregate modulus estimated from confined compression is a uniaxial measure of
compressive stiffness, that does not allow for direct measurement of the Poisson’s ratio of the
tissue; therefore, the estimation of Young’s modulus as needed for the finite element model is
based on incomplete knowledge of the synovial elastic properties. An alternative could be the
unconfined compression test which, when combined with imaging to measure transverse
deformations, would enable direct measurement of both Poisson’s ratio and Young’s modulus.
Another alternate method to measure Poisson’s ratio would be to perform planar tensile testing
with imaging to track the deformations, however this method would estimate the tensile
properties and other tissues have displayed differences between tensile and compressive
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properties. Indentation is another widely used mechanical test to determine mechanical behavior
of tissues that could be used to obtain these properties for synovium in compression. The
aggregate modulus here also only considers the solid phase but does not account for any
dilatation that arises from osmotic swelling. The force response during an isometric swelling test
in the confining chamber would be able to measure the swelling pressure to account for osmotic
effects.
Synovial tissue was found to have moduli on the order of 1-10 kPa and hydraulic
permeabilities on the order of 10-19 m4/N.s; values lower than those found in other connective
tissues as well as lower than what was used in chapters 2 and 3. These new found values will be
used to refine the predictions of effective diffusivity in chapter 3, though preliminary results
suggest these values still lead to similar conditions as based on the assumptions from chapter 2.
This dissertation provides important data on the roles of solute size and tissue properties
on trans-synovial transport and IA clearance. However, much more work remains to understand
the exact importance of drug characteristics such as charge and active transport in synovial
transport. Future studies utilizing the methods developed here incorporating charged solutes and
synovium with viable cells would elucidate the role of each factor in drug transport. To properly
model the effects of charge, the fixed charge density of synovial tissue would need to be
measured. One method of measuring fixed charge density could be from measuring the
conductivity of the tissue in two different concentration salt solutions. Following these
measurements, a simulation of charged species transport could be performed to quantify the
effects of charge prior to any transport experiments. To address the role of active transport,
synovial tissue would need to be cultured to maintain cell viability, and solutes for transport
experiments would ideally be selected of similar molecular weights as used in this dissertation
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for comparison. Challenges here would include maintaining cell viability in the tissue over the
duration of the transport experiment and may limit the study to a shorter time span than the 72
hours used here. These studies of transport in healthy synovium would further the knowledge of
drug characteristics in order to increase residence times.
The ultimate goal would be to study pathological tissue to provide insight into how drug
clearance kinetics change in disease. Surgical tissue from end-stage patients undergoing knee
arthroplasty could be obtained, though not without challenges. The primary challenge would be
recovering useable synovial tissue due to the size requirements of the chamber designed here;
tissue would be 15 mm x 15 mm at a minimum. Another problem would be maintaining
orientation of the tissue due to the heterogeneous structure of the synovium, with the intima and
the sub-intima. However, another future study could be to remove the intimal layer and study the
sub-intima only, which could help answer the question on whether the intimal layer acts as a
steric barrier to transport.
While this dissertation has investigated properties of synovium as it relates to transport
and mechanical behavior, it does not relate these properties to any of the microstructure. The
lack of imaging of the tissue remains a limitation of this study. To address this limitation, thick
sections perpendicular to the plane of the membrane could be cut in order to image the collagen
structure via second harmonic generation and molecular labeling with antibodies as done by
Hasegawa and co-workers (2020). To increase the depth penetration due to the thick sections,
optical clearing techniques can be utilized. Finally, immunostaining for the presence of vessels in
these thick sections would then provide information on the density of the capillary and lymphatic
beds and their relative depth present in the sub-intima. The information on the microstructure
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when combined with the transport and mechanical data presented in this thesis would help
understand the structure-function relationship within synovium.
Overall, the models and data presented in this dissertation report the first studies of transsynovial transport. These findings identify the relationship between solute molecular weight and
intrinsic diffusion properties of the synovium, and also further our understanding of the
synovium as it relates to molecular and fluid transport.
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